Late blight resistance gene from wild potato

TECHNICAL FIELD

This invention relates to the fields of plant physiology, genetics, and molecular biology. In particular, the invention provides biological protection of plants against microbial infections using novel genes, proteins, and methods of enhancing disease resistance in plants.

BACKGROUND

Potato (Solanum tuberosum L.) is the world's fourth most valuable crop. In the United States of America, the value of the crop exceeds two billion dollars each year. Worldwide production of the cultivated potato exceeds that of all other dicot food crops. Potato is also host to more than sixty pathogens of economic significance, causing costly diseases in terms of crop loss. The expenses associated with application of chemicals, and the environmental impact of pesticide use, are significant. Such costs could be minimized or avoided if resistant potato varieties were available. However, adequate resistance for many diseases has not been incorporated into potato cultivars, partly because of the lack of resistance genes that breeders can use to develop resistant cultivars.

Among the most devastating potato diseases is late blight, a foliar and tuber disease caused by the oomycete pathogen Phytophthora infestans (P. infestans), the causative agent of the legendary Great Irish Potato Famine of 1845. The late blight fungus is also a devastating pathogen on crops other than potato; it infects tomatoes, eggplants, and other solanaceous species. To combat the disease caused by P. infestans, growers use a combination of practices, such as sanitary measures, resistant cultivars, and fungicides. The fungicide approach has repeatedly failed due to the remarkable ability of P. infestans to acquire resistance. The attempted breeding of disease resistant strains of Solanum tuberosum (S. tuberosum), the cultivated species of potato, has also failed over time.

Possible sources of resistance to many potato pathogens exist in the approximately 225 wild Solanum species. Several Solanum species have been crossed with the cultivated potato in an effort to introgress disease-resistance genes, including genes that confer resistance to late blight disease (Jansky, 2000, Plant Breed. Rev. 19: 69-155). Among wild potato species with late blight resistance is the hexaploid Solanum demissum. Resistance from this species has been incorporated into potato via sexual crosses. Eleven race-specific resistance genes conferring late blight resistance have been described in Solanum demissum (Malcolmson and Black, 1966, Euphytica 15:199-203), and introgressed into cultivated potato varieties using classical breeding. These genes are characterized by pathogen race specificity and a hypersensitive phenotype. Unfortunately, virulent races of P. infestans have rapidly overcome the majority of these 11 late blight resistance genes in most potato growing regions (Fry and Goodwin, 1997, Plant Disease 81: 1349-1357).

Because P. infestans is capable of acquiring resistance, efforts have been directed toward the identification of additional late blight resistance genes in wild potato species that are naturally resistant to P. infestans. For example, Rpi1, a late blight resistance gene from Solanum pinnatisectum, was described and mapped by Kuhl et al., 2001, Mol. Genet. Genomics 265: 977-985. Rpi1 has never been deployed for potato protection and the durability potential of Rpi1 remains unexplored. In addition, to confer late blight resistance, somatic hybrids between cultivated potato and the wild Mexican diploid Solanum bulbocastanum (S. bulbocastanum) have also been generated. Such somatic hybrids retained the late blight resistance of the wild species, and could be backcrossed to cultivated potato (Helgeson et al., 1998, Theor. Appl. Genet. 96: 738-742). Mapping experiments revealed a single locus on Solanum bulbocastanum chromosome 8 that imparted the late blight resistance phenotype (Naess et al., 2000, Theor. Appl. Genet. 101: 697-704). This region was dubbed RB (resistance region from S. bulbocastanum), and a gene from S. bulbocastanum that confers late blight resistance is referred to as RB.sup.blb.

The global food shortage crisis has highlighted the importance of the ongoing quest for materials and methods for conferring disease resistance in plants, for example as disclosed in International Patent Application Publication No. WO/1999/009151, and in particular the quest for potato genes for resistance to late blight, as disclosed in U.S. Patent Application No. 2005/0204419 A1. However, despite decades of active breeding effort to control late blight, this disease still causes the loss of billions of revenue dollars for growers each year (Kamoun, 2001, Curr. Opin. Plant Biol. 4: 295-300). Accordingly, a source of resistance to Phytophthora species that could be introduced into the cultivated species by molecular genetic techniques would be of great value. As a result, there is an ongoing need to identify genes that might confer late blight disease resistance. If such genes can be identified and isolated, they can be introduced by molecular genetic techniques into domestic potato and species other than potato to confer resistance to one or more plant pathogens. The products of such research are in demand by potato growers, who keep looking for novel varieties containing genes and other factors that promote resistance to P. infestans and related pathogens. The present invention addresses these and other related needs.

BRIEF SUMMARY

Isolated polynucleotides are provided, which encode polypeptides comprising amino acid sequences that are at least 95% identical to SEQ ID NO:2. These polypeptides confer disease resistance in solanaceous plants. The isolated polynucleotides may include nucleic acid sequences that are at least 95% identical to SEQ ID NO:1. The isolated polynucleotides may encode the amino acid sequence of SEQ ID NO:2. The polynucleotides may be isolated from Solanum verrucosum (S. verrucosum). The isolated polynucleotides may encode polypeptides that confer disease resistance to oomycete pathogens, such as, for example, Phytophthora infestans. The isolated polynucleotides may encode polypeptides that confer disease resistance in plants selected from the group consisting of potato, tomato, and eggplant.

Vectors are provided, which include the isolated polynucleotides of the present invention. The vectors may comprise recombinant expression cassettes that include promoter sequences operably linked to polynucleotides encoding: (a) polypeptides comprising amino acid sequences that are at least 95% identical to SEQ ID NO:2; or (b) polynucleotides encoding polypeptides that comprise at least 912 amino acids of SEQ ID NO:2. These polypeptides confer disease resistance in solanaceous plants. Also provided are host cells transformed with these vectors.

Isolated polypeptides are provided, which include amino acid sequences that are at least 95% identical to SEQ ID NO:2, where the polypeptides confer disease resistance in solanaceous plants. The isolated polypeptides may include the amino acid sequence of SEQ ID NO:2. The isolated polypeptides may confer disease resistance to oomycete pathogens, such as, for example, Phytophthora infestans. Also provided are antibodies immunologically specific for the polypeptides of the present invention.

Transgenic plants are provided, which include isolated polynucleotides that encode polypeptides comprising amino acid sequences that are at least 95% identical to SEQ ID NO:2. These polypeptides confer disease resistance in the transgenic plants. The transgenic plants may be, for example, transgenic potato, tomato, or tobacco. The transgenic plants are preferably resistant to Phytophthora infestans.

Transgenic plants are also provided, which include recombinant expression cassettes comprising promoter sequences operably linked to polynucleotides, which encode polypeptides that include amino acid sequences at least 95% identical to SEQ ID NO:2. These transgenic plants express polypeptides that are encoded by the polynucleotides of the present invention. The transgenic plants of the present invention may include transgenic potato, tomato, or tobacco. The transgenic plants are preferably resistant to Phytophthora infestans.

Methods of enhancing disease resistance in solanaceous plants are provided. The methods include introducing into the solanaceous plants recombinant expression cassettes that include promoters operably linked to polynucleotides encoding polypeptides that comprise amino acid sequences that are at least 95% identical to SEQ ID NO:2. The methods may be used to enhance disease resistance in solanaceous plants such as potato, tomato, or tobacco. The methods may be used to enhance disease resistance to oomycete pathogens, such as, for example, Phytophthora infestans.

BRIEF DESCRIPTION OF THE DRAWINGS

FIG. 1 illustrates parts of the predicted RB.sup.ver protein sequence from Solanum verrucosum ortholog PI 275260 (SEQ ID NO: 15) and the sequences of 21 leucine-rich repeats (LRR; SEQ ID Nos: 16-36) that are repeated elements in the second part of the protein.

FIG. 2 is a multiple sequence alignment of the LRR regions of RB.sup.blb from Solanum bulbocastanum (SEQ ID NO: 37) and eight RB.sup.ver orthologs from Solanum verrucosum (PI 558485, PI 275258, PI 310966, PI 116173, PI 275256, PI 570643, PI 275260, and PI 365404; (SEQ ID NOs: 38-45respectively ).

FIG. 3 is an image of an electrophoretogram showing reverse transcription-PCR (RT-PCR) products of RB.sup.ver orthologs, which were obtained using a pair of gene-specific primers.

FIG. 4 is a dendrogram illustrating clustering analysis of open reading frames of RB.sup.blb and eight RB.sup.ver orthologs (PI 558485, PI 275258, PI 310966, PI 116173, PI 275256, PI 570643, PI 275260, and PI 365404).

FIG. 5 is a graph that illustrates posterior probabilities for site classes (.omega.>1) estimated under the discrete model M3 in the PAML software package along the RB.sup.ver orthologous protein sequence.

DETAILED DESCRIPTION OF THE PRESENTLY PREFERRED EMBODIMENTS

The present invention is directed toward the isolation and identification of a late blight resistance gene from Solanum verrucosum, the protein that it encodes, its use for the control of plant diseases, and as a source for making transgenic plants with resistance to phytopathogenic microorganisms, in particular Phytophthora infestans. A late blight resistance gene ("RB gene"), which encodes a late blight resistance protein ("RB protein" or "RB polypeptide"), has been identified and cloned from the wild potato species Solanum verrucosum. A gene from S. verrucosum that confers late blight resistance is also herein referred to as RB.sup.ver. For use in the present invention, the terms "RB" or "RB.sup.ver" also refer to polymorphic variants, mutants, alleles, and interspecies homologs of the late blight resistance RB gene and protein cloned from Solanum verrucosum (i.e., RB.sup.ver). RB genes and proteins of the present invention modulate disease resistance in plants. The RB genes and proteins of the present invention confer disease resistance in plants; in particular, they confer late blight disease resistance in solanaceous plants, including in plant species of the genus Solanum.

Generally, the nomenclature used herein and the laboratory procedures utilized in the present invention include molecular, biochemical, microbiological and recombinant DNA techniques that are well known and commonly employed in the art. Standard techniques are used for cloning, DNA and RNA isolation, amplification and purification. Generally enzymatic reactions involving DNA ligase, DNA polymerase, restriction endonucleases and the like are performed according to the manufacturer's specifications. Such techniques are thoroughly explained in the literature and are generally performed according to Sambrook et al., 1989, Molecular Cloning--A Laboratory Manual, Cold Spring Harbor Laboratory, Cold Spring Harbor, New York, N.Y.; Ausubel et al., 1993, Current Protocols in Molecular Biology, Volumes 1-3, John Wiley & Sons, Inc., Hoboken, N.J.; and Kriegler, 1990, Gene Transfer and Expression: A Laboratory Manual, Stockton Press, New York, N.Y.; Perbal, 1988, A Practical Guide to Molecular Cloning, 2.sup.nd edition, John Wiley & Sons, New York, N.Y.; Watson et al., 1992, Recombinant DNA, 2.sup.nd edition, Freeman & Co., New York, N.Y.; Bartlett and Stirling, 2003, PCR Protocols, 2.sup.nd edition, Humana Press, Totowa, N.J.; all of which are incorporated herein by reference.

It has been discovered that the wild potato species Solanum verrucosum contains in its genetic material a region with novel disease resistance genes. One or more of these genes impart resistance to pathogens, including resistance to Phytophthora infestans. Using as a starting point the RB gene sequence from Solanum bulbocastanum (RB.sup.blb) described by Naess et al., 2000, Theor. App. Genet. 101: 697-701, the inventors isolated and identified an RB-like gene in S. verrucosum. This RB (i.e., RB.sup.ver) late blight resistance gene from S. verrucosum is 84% identical to the S. bulbocastanum RB gene at the nucleotide level, and encodes a putative amino acid (RB polypeptide) that is 77% similar at the amino acid level to that encoded by the RB.sup.blb gene. The isolated and identified sequence of the RB.sup.ver gene from S. verrucosum has been deposited on Dec. 29, 2006 in the GenBank under accession number EF202329. The nucleic acid sequence of the late blight resistance gene RB.sup.ver from S. verrucosum is shown as SEQ ID NO:1. The amino acid sequence of the late blight resistance protein RB.sup.ver from S. verrucosum, encoded by the RB.sup.ver gene, is 960 amino acids long, and is shown as SEQ ID NO:2. The coding region of the late blight resistance gene RB.sup.ver from S. verrucosum is shown as SEQ ID NO:3

An "RB (also RB.sup.ver) polynucleotide" of the present invention: (1) comprises a nucleic acid sequence that includes a coding region of from about 50 to about 10,000 nucleotides, sometimes from about 100 to about 6,000 nucleotides, and preferably from about 500 to about 4,000 nucleotides, which hybridizes to SEQ ID NO:1 or the complement thereof under stringent conditions (as defined below), and also includes conservatively modified variants thereof; (2) has substantial identity to the polynucleotide sequence of SEQ ID NO:1; and (3) encodes an RB (also RB.sup.ver) polypeptide.

The phrase "nucleic acid" or "polynucleotide sequence" refers to a single-stranded or double-stranded polymer of deoxyribonucleotide or ribonucleotide bases read from the 5' to the 3' end. Nucleic acids may also include modified nucleotides that permit correct read-through by a polymerase and do not alter expression of a polypeptide encoded by that nucleic acid.

A "coding sequence" or "coding region" refers to a nucleic acid molecule having sequence information necessary to produce a gene product, when the sequence is expressed. The phrase "nucleic acid sequence encoding" refers to a nucleic acid which directs the expression of a specific protein or polypeptide. The nucleic acid sequences of this invention include both the DNA strand sequence that is transcribed into RNA and the RNA sequence that is translated into protein. The nucleic acid sequences include both the full length nucleic acid sequences as well as non-full length sequences derived from the full length sequences. It should be understood that the sequences include the degenerate codons of the native sequence or sequences which may be introduced to provide codon preference in a specific host cell.

The terms "isolated," "purified," or "biologically pure" refer to material that is substantially or essentially free from components that normally accompany it as found in its native state. Purity and homogeneity are typically determined using molecular biology and analytical chemistry techniques such as polyacrylamide gel electrophoresis or high performance liquid chromatography. A protein that is the predominant species present in a preparation is substantially purified. In particular, an isolated nucleic acid of the present invention is separated from open reading frames that flank the desired gene and encode proteins other than the desired protein. The term "purified" denotes that a nucleic acid or protein gives rise to essentially one band in an electrophoretic gel. Particularly, it means that the nucleic acid or protein is at least 85% pure, more preferably at least 95% pure, and most preferably at least 99% pure.

In one embodiment of the present invention, provided are eight late blight resistance gene orthologs, and late blight resistance phenotypes of eight accessions of S. verrucosum: PI 558485, PI 275258, PI 310966, PI 116173, PI 275256, PI 570643, PI 275260, and PI 365404. "Orthologs" or "orthologous genes" are any genes in different species, which are similar to each other and originated from a common ancestor. Orthologs are typically separated by an evolutionary speciation event: if a gene exists in a species, and that species diverges into two species, then the divergent copies of this gene in the resulting species are orthologous. An "ortholog gene" may also refer to a gene with a similar function in different species. "Accession" refers to a plant or group of similar plants received from a single source at a single time. Each accession is assigned a unique accession number (PI numbers herein). As described below, transcribed orthologs of the RB gene from eight S. verrucosum accessions were cloned using a homology-based PCR approach. Sequence analysis revealed that the isolated RB.sup.ver orthologs share up to 83.5% nucleotide identity with RB.sup.blb from Solanum bulbocastanum.

In another embodiment of the present invention, provided are isolated nucleic acids that encode polypeptides which, when produced in plants, confer disease resistance in the plants, particularly solanaceous plants, and most particularly plants from the genus Solanum. For example, isolated nucleic acids comprising polynucleotides at least 80% identical to a sequence as shown in SEQ ID NO:1 are provided. The present invention also provides isolated nucleic acids comprising polynucleotides at least 90% identical to a sequence as shown in SEQ ID NO:1. Yet in other examples, isolated nucleic acids comprising polynucleotides that are at least 95% identical to a sequence as shown in SEQ ID NO:1 are provided.

Also provided are isolated nucleic acids, which include polynucleotide sequences that hybridize under stringent conditions to a sequence as shown in SEQ ID NO:1 or the complement thereof, where the nucleic acids encode polypeptides that confer late blight resistance. SEQ ID NO:1 is an example of such polynucleotide sequences of the present invention. In some embodiments, the nucleic acids of the present invention encode polypeptide sequences that are at least 80% identical to the polypeptide sequence as shown in SEQ ID NO:2. In other embodiments, the nucleic acids of the present invention encode polypeptide sequences that are at least 90% identical to the polypeptide sequence as shown in SEQ ID NO:2. In yet other embodiments, the nucleic acids of the present invention encode polypeptide sequences that are at least 95% identical to the polypeptide sequence as shown in SEQ ID NO:2. The polypeptides of the present invention confer disease resistance to microbial pathogens. These microbial pathogens may include, for example, an oomycete fungus, such as Phytophthora infestans.

The polynucleotides of the present invention encode polypeptides useful for conferring disease resistance in plants, e.g., resistance to late blight. Methods of determining whether a polypeptide is useful for conferring disease resistance in a plant are described below.

An "RB polypeptide" of the present invention has substantial identity to the amino acid sequence of SEQ ID NO:2 and/or binds to antibodies raised against an immunogen comprising an amino acid sequence of SEQ ID NO:2. Preferred polypeptides of the present invention confer disease resistance in a plant, and in particular, confer resistance to Phytophthora disease-causing agents, for example Phytophthora infestans. SEQ ID NO:2 is an example of the polypeptides of the present invention. In addition, the polypeptides of the present invention include polymorphic variants, mutants, and interspecies homologs of SEQ ID NO:2. Polypeptides of the present invention also include functional equivalents or fragments of SEQ ID NO:2. In one embodiment, an RB polypeptide of the present invention has substantial identity to an amino acid sequence of SEQ ID NO:2 and/or is encoded by a polynucleotide that hybridizes under stringent conditions to SEQ ID NO:1 or the complement thereof, and comprises one or more of the following domains or motifs: kinase 1a or P-loop domain, kinase 2 domain, kinase 3a domain, QLPL domain, CFAY domain, MHD domain, five-heptad leucine zipper motif, four-heptad repeat motif, and 21 LRRs (leucine-rich repeats). Some of these domains or motifs are shown in the examples section below.

A functional fragment or functional equivalent or functional homolog of a polypeptide of the present invention is a polypeptide that is homologous to the specified polypeptide but has one or more amino acid differences from the specified polypeptide. A functional fragment or equivalent of a polypeptide retains at least some, if not all, of the activity of the specified polypeptide.

In general, an RB polypeptide functional homolog that preserves RB polypeptide-like function includes any homolog in which residues at a particular position in the sequence have been substituted by other amino acids, and further includes the possibility of inserting an additional residue or residues between two residues of the parent protein as well as the possibility of deleting one or more residues from the parent sequence. Any amino acid substitution, insertion, or deletion is encompassed by the invention. The amino acid substitution may be a conservative substitution. Conservative substitutions whereby an amino acid of one class is replaced with another amino acid of the same type fall within the scope of the invention so long as the substitution does not materially alter the biological activity of the compound. For example, a functional equivalent of SEQ ID NO:2 shares the same amino acid sequence as SEQ ID NO:2 except for a few amino acid differences, e.g., substitutions, insertions, or deletions. When expressed in a plant, for example a plant from the Solanaceae family, both SEQ ID NO:2 and its functional homolog confer disease resistance to late blight.

Provided are promoters, as segments of an isolated nucleic acid molecule for regulating expression of genes in transformed cells, and particularly in transformed plant cells. In one example, the segments may comprise a portion of a gene that confers resistance to Phytophthora. These segments typically commence at a location about 2,500, and preferably about 2,000, bases upstream from a transcription initiation site of the gene that confers resistance to Phytophthora, and end at locations about 250 bases downstream from the transcription initiation site. These segments are capable of increasing promoter activity of homologous or heterologous promoters in plant species. In one example, the segment may include a 3' untranslated region commencing at a stop codon for the gene's coding sequence, and ending at a location about 5,000 bases downstream from the gene's transcription initiation site.

DNA segments for effecting expression of coding sequences operably linked to the segments are provided as well. These DNA segments are typically isolated from a gene whose coding region hybridizes under stringent conditions with a coding region defined by SEQ ID NO:1. The DNA segment may comprise a promoter and a transcription initiation site, and it may include a polyadenylation signal. The DNA segment may be isolated from a S. verrucosum RB gene.

In one embodiment of the present invention, provided are recombinant expression cassettes that include a promoter sequence operably linked to a nucleic acid of the present invention. The nucleic acid may include a polynucleotide sequence at least 80% identical to a polynucleotide sequence as shown in SEQ ID NO:1. The nucleic acid may be operably linked to the promoter in a sense or antisense orientation.

In another embodiment, provided are recombinant expression cassettes that include a promoter sequence operably linked to a nucleic acid comprising a polynucleotide sequence which hybridizes under stringent conditions to a sequence as shown in SEQ ID NO:1 or the complement thereof, where the nucleic acid encodes an RB polypeptide. The term "recombinant" when used with reference, e.g., to a cell, nucleic acid, protein, expression cassette, or vector, indicates that the cell, nucleic acid, protein, expression cassette, or vector, has been modified by the introduction of a heterologous nucleic acid or protein, or it indicates the alteration of a native nucleic acid or protein, or that the cell is derived from a cell so modified. Thus, for example, recombinant cells express genes that are not found within the native (non-recombinant) form of the cell or express native genes that are otherwise abnormally expressed, are underexpressed, or are not expressed at all.

An "expression cassette" refers to a nucleic acid construct, which when introduced into a host cell, results in transcription and/or translation of a RNA and/or polypeptide, respectively. The expression cassette may include a nucleic acid comprising a promoter sequence, with or without a sequence containing mRNA polyadenylation signals, and one or more restriction enzyme sites located downstream from the promoter allowing insertion of heterologous gene sequences. The expression cassette is capable of directing the expression of a heterologous protein when the gene encoding the heterologous protein is operably linked to the promoter by insertion into one of the restriction sites. The recombinant expression cassette allows expression of the heterologous protein in a host cell when the expression cassette containing the heterologous protein is introduced into the host cell. Expression cassettes can be derived from a variety of sources depending on the host cell to be used for expression. For example, an expression cassette can contain components derived from a viral, bacterial, insect, plant, or mammalian source. In the case of both expression of transgenes and inhibition of endogenous genes (e.g., by antisense, or sense suppression) the inserted polynucleotide sequence need not be identical and can be "substantially identical" to a sequence of the gene from which it was derived. Preferably the recombinant expression cassette allows expression at an early stage of infection and/or it allows expression in substantially all cells of an organism, such as a plant. Examples of expression cassettes suitable for transformation of plants can be found in U.S. Pat. Nos. 5,880,333 and 6,002,072; International Patent Publications Nos. WO/1990/002189 and WO/2000/026388; Ainley and Key, 1990, Plant Mol. Biol. 14: 949-967; and Birch, 1997, Annu. Rev. Plant Physiol. Plant Mol. Biol. 48: 297-326, all of which are herein incorporated by reference.

The term "host cell" refers to a cell from any organism. Preferred host cells are derived from plants, bacteria, yeast, fungi, insects, or other animals. The term "recombinant host cell" (or simply "host cell") refers to a cell into which a recombinant expression vector has been introduced. It should be understood that the term "host cell" is intended to refer not only to the particular subject cell but to the progeny of such a cell. Because certain modifications may occur in succeeding generations due to either mutation or environmental influences, such progeny may not, in fact, be identical to the parent cell, but are still included within the scope of the term "host cell" as used herein. Methods for introducing polynucleotide sequences into various types of host cells are well known in the art. Provided are host cells or progeny of host cells transformed with the recombinant expression cassettes of the present invention. The host cells may be plant cells. Preferably, the plant cells are potato cells.

The term "operably linked" or "operably inserted" means that the regulatory sequences necessary for expression of the coding sequence are placed in a nucleic acid molecule in the appropriate positions relative to the coding sequence so as to enable expression of the coding sequence. This same definition is sometimes applied to the arrangement of other transcription control elements (e.g. enhancers) in an expression cassette. Transcriptional and translational control sequences are DNA regulatory sequences, such as promoters, enhancers, polyadenylation signals, terminators, and the like, that provide for the expression of a coding sequence in a host cell.

The terms "promoter," "promoter region," or "promoter sequence" refer generally to transcriptional regulatory regions of a gene, which may be found at the 5' or 3' side of the coding region, or within the coding region, or within introns. Typically, a promoter is a DNA regulatory region capable of binding RNA polymerase in a cell and initiating transcription of a downstream (3' direction) coding sequence. The typical 5' promoter sequence is bounded at its 3' terminus by the transcription initiation site and extends upstream (5' direction) to include the minimum number of bases or elements necessary to initiate transcription at levels detectable above background. Within the promoter sequence is a transcription initiation site (conveniently defined by mapping with nuclease S1), as well as protein binding domains (consensus sequences) responsible for the binding of RNA polymerase.

The term "nucleic acid construct" or "DNA construct" is sometimes used to refer to a coding sequence or sequences operably linked to appropriate regulatory sequences and inserted into an expression cassette for transforming a cell. This term may be used interchangeably with the term "transforming DNA" or "transgene". Such a nucleic acid construct may contain a coding sequence for a gene product of interest, along with a selectable marker gene and/or a reporter gene. The term "selectable marker gene" refers to a gene encoding a product that, when expressed, confers a selectable phenotype such as antibiotic resistance on a transformed cell. The term "reporter gene" refers to a gene that encodes a product which is easily detectable by standard methods, either directly or indirectly.

A "heterologous" region of a nucleic acid construct is an identifiable segment (or segments) of the nucleic acid molecule within a larger molecule that is not found in association with the larger molecule in nature. When the heterologous region encodes a plant gene, the gene will usually be flanked by DNA that does not flank the plant genomic DNA in the genome of the source organism. In another example, a heterologous region is a construct where the coding sequence itself is not found in nature (e.g., a cDNA where the genomic coding sequence contains introns, or synthetic sequences having codons different than the native gene). Allelic variations or naturally-occurring mutational events do not give rise to a heterologous region of DNA as defined herein. The term "DNA construct" is also used to refer to a heterologous region, particularly one constructed for use in transformation of a cell.

The term "vector" is intended to refer to a nucleic acid molecule capable of transporting another nucleic acid to which it has been linked. One type of vector is a "plasmid," which refers to a circular double-stranded DNA loop into which additional DNA segments may be ligated. Another type of vector is a viral vector, where additional DNA segments may be ligated into the viral genome. Certain vectors are capable of autonomous replication in a host cell into which they are introduced (e.g., bacterial vectors having a bacterial origin of replication and episomal mammalian vectors). Other vectors can be integrated into the genome of a host cell upon introduction into the host cell, and thereby are replicated along with the host genome. Moreover, certain vectors are capable of directing the expression of genes to which they are operatively linked. Such vectors are referred to herein as "recombinant expression vectors" (or simply, "expression vectors"). In general, expression vectors of utility in recombinant DNA techniques are often in the form of plasmids. In the present specification, "plasmid" and "vector" may be used interchangeably as the plasmid is the most commonly used form of vector. However, the invention is intended to include such other forms of expression vectors, such as viral vectors (e.g., replication defective retroviruses, adenoviruses and adeno-associated viruses), which serve equivalent functions.

Antisense polynucleotides are also provided. For example, the invention provides antisense oligonucleotides complementary to SEQ ID NO:1 or a fragment thereof. In one embodiment, the antisense polynucleotides are less than about 200 bases in length.

In one embodiment of the present invention, provided are transgenic plants having enhanced resistance to plant pathogens and other disease-causing agents, such as an oomycete fungus. In particular, transgenic plants having enhanced resistance to the Phytophthora species, e.g., Phytophthora infestans, are provided. Transgenic plants of the present invention may include recombinant expression cassettes comprising a promoter operably linked to a nucleic acid of the present invention. The nucleic acid can be operably linked to a promoter sequence in a sense or antisense orientation. These transgenic plants having enhanced resistance to plant pathogens may be selected from the Solanaceae family. The plant may be selected from the Solanum genus, and in particular the plant species may be Solanum tuberosum. For example, stable introduction of the RB ortholog PI 275260 from late blight resistant S. verrucosum into susceptible S. tuberosum confers resistance to P. infestans in S. tuberosum. Notably, this functional RB.sup.ver ortholog (PI 275260) contains an insertion of a complete leucine rich repeat when compared to RB.sup.blb, and differs from a non-functional ortholog at only four amino acid residues.

The term "plant" includes whole plants, shoot vegetative organs/structures (e.g., leaves, stems, and tubers), roots, flowers, and floral organs/structures (e.g., bracts, sepals, petals, stamens, carpels, anthers, and ovules), seed (including embryo, endosperm, and seed coat) and fruit (the mature ovary), plant tissue (e.g., vascular tissue, ground tissue, and the like) and cells (e.g., guard cells, egg cells, trichomes and the like), and progeny of same. The class of plants that can be used in the method of the invention is generally as broad as the class of higher and lower plants amenable to transformation techniques, including angiosperms (monocotyledonous and dicotyledonous plants), gymnosperms, ferns, bryophytes, and multicellular algae. It includes plants of a variety of ploidy levels, including aneuploid, polyploid, diploid, haploid, and hemizygous.

A cell has been "transformed" or "transfected" by exogenous or heterologous DNA when such DNA has been introduced inside the cell. The transforming DNA may or may not be integrated (covalently linked) into the genome of the cell. In prokaryotes, yeast, and mammalian cells for example, the transforming DNA may be maintained on an episomal element such as a plasmid. With respect to eukaryotic cells, a stably transformed cell is one in which the transforming DNA has become integrated into a chromosome so that it is inherited by daughter cells through chromosome replication. The practice of the present invention contemplates a wide variety of stably transformed plant cells.

Methods are provided for enhancing disease resistance in plants. The methods include introducing a construct comprising a promoter operably linked to a nucleic acid of the present invention, and optionally, selecting for a plant with a phenotype associated with enhanced disease resistance. In some embodiments, a plant with enhanced disease resistance will be healthier and it may live longer than a wild type plant when exposed to a disease-causing agent. Enhanced disease resistance can be measured according to any method known in the art. For example, a disease symptom in a test plant can be compared to a disease symptom in a control plant following contact with a pathogen, for example Phytophthora infestans.

Kits are also provided for enhancing disease resistance in plants. An example of a kit according to the present invention includes a construct comprising a promoter operably linked to a nucleic acid of the present invention and instructions for producing a transgenic plant cell using the construct.

Methods of detecting RB polynucleotides in a sample are provided as well. This may be achieved by first contacting the sample with an RB polynucleotide of the present invention or a complement thereof, or contacting the sample with a polynucleotide that comprises a sequence of at least 12 nucleotides and is complementary to a contiguous sequence of an RB polynucleotide of the present invention. Then, it is determined whether a hybridization complex has been formed. In one example, the at least 12 nucleotide sequence will comprise a domain conserved among resistance (RB) genes.

Expression regulatory elements are also provided, and in particular a native promoter or variant of a native promoter from Solanum verrucosum that can be used to express the genes and proteins of the present invention, e.g., SEQ ID NO:1 or SEQ ID NO:1 homologs. In one embodiment, the promoter is a native promoter from S. verrucosum that controls expression of the RB gene.

A "nucleic acid probe" or "oligonucleotide" is defined as a nucleic acid capable of binding to a target nucleic acid of complementary sequence through one or more types of chemical bonds, usually through complementary base pairing, usually through hydrogen bond formation. As used herein, a probe may include natural bases (i.e., A, G, C, or T) or modified bases (7-deazaguanosine, inosine, etc.). In addition, the bases in a probe may be joined by a linkage other than a phosphodiester bond, so long as it does not interfere with hybridization. For example, probes may be peptide nucleic acids (PNAs) in which the constituent bases are joined by peptide bonds rather than phosphodiester linkages. It will be understood that probes may bind target sequences lacking complete complementarity with the probe sequence depending upon the stringency of the hybridization conditions. The probes are preferably directly labeled as with isotopes, chromophores, lumiphores, chromogens, or indirectly labeled such as with biotin to which a streptavidin complex may later bind. By assaying for the presence or absence of the probe, one can detect the presence or absence of the select sequence or subsequence (sequence fragment).

A polynucleotide "exogenous to" an individual plant is a polynucleotide which is introduced into the plant, or a predecessor generation of the plant, by any means other than by a sexual cross. Examples of means by which this can be accomplished are described below, and include Agrobacterium-mediated transformation, biolistic methods, electroporation, microinjection, in planta transformation techniques, and the like.

"Increased or enhanced expression or activity of a polypeptide of the present invention," or "increased or enhanced expression or activity of a polynucleotide encoding a polypeptide of the present invention," refers to an augmented change in activity of the polypeptide or protein. Examples of such increased expression or activity include the following: (1) activity of the protein or expression of the gene encoding the protein is increased above the level of that in wild-type, non-transgenic control plants; (2) activity of the protein or expression of the gene encoding the protein is in an organ, tissue or cell where it is not normally detected in wild-type, non-transgenic control plants (i.e., spatial distribution of the protein or expression of the gene encoding the protein is altered); (3) activity of the protein or expression of the gene encoding the protein is increased when activity of the protein or expression of the gene encoding the protein is present in an organ, tissue or cell for a longer period than in a wild-type, non-transgenic controls (i.e., duration of activity of the protein or expression of the gene encoding the protein is increased).

"Decreased expression or activity of a protein or polypeptide of the present invention," or "decreased expression or activity of a nucleic acid or polynucleotide encoding a protein of the present invention," refers to a decrease in activity of the protein. An example of such decreased activity or expression includes the decrease in activity of the protein or expression of the gene encoding the protein below the level of that in wild-type, non-transgenic control plants.

Two nucleic acid sequences or polypeptides are said to be "identical" if the sequence of nucleotides or amino acid residues, respectively, in the two sequences is the same when aligned for maximum correspondence as described below. The term "complementary to" is used herein to mean that the sequence is complementary to all or a portion of a reference polynucleotide sequence. In the case of both expression of transgenes and inhibition of endogenous genes (e.g., by antisense or sense suppression) the inserted polynucleotide sequence need not be identical and may be "substantially identical" to a sequence of the gene from which it was derived. As explained below, these variants are specifically covered by this term.

In the case where the inserted polynucleotide sequence is transcribed and translated to produce a functional polypeptide, because of codon degeneracy, a number of polynucleotide sequences will encode the same polypeptide. These variants are specifically covered by the term "polynucleotide sequence from" a particular gene. In addition, the term specifically includes sequences (e.g., full length sequences) that are substantially identical (determined as described below) with a gene sequence encoding a protein of the present invention and that encode proteins or functional fragments that retain the function of a protein of the present invention, e.g., resistance to disease-causing agents such as Phytophthora infestans.

In the case of polynucleotides used to inhibit expression of an endogenous gene, the introduced sequence need not be perfectly identical to a sequence of the target endogenous gene. The introduced polynucleotide sequence will typically be at least substantially identical (as determined below) to the target endogenous sequence.

Optimal alignment of sequences for comparison may be conducted by methods commonly known in the art, for example by the search for similarity method described by Pearson and Lipman 1988, Proc. Natl. Acad. Sci. USA 85: 2444-2448, by computerized implementations of algorithms such as GAP, BESTFIT, BLAST, FASTA, and TFASTA in the Wisconsin Genetics Software Package, Genetics Computer Group (GCG), Madison, Wis., or by inspection. In a preferred embodiment, protein and nucleic acid sequence identities are evaluated using the Basic Local Alignment Search Tool ("BLAST"), which is well known in the art (Karlin and Altschul, 1990, Proc. Natl. Acad. Sci. USA 87: 2267-2268; Altschul et al., 1997, Nucl. Acids Res. 25: 3389-3402), the disclosures of which are incorporated by reference in their entireties. The BLAST programs identify homologous sequences by identifying similar segments, which are referred to herein as "high-scoring segment pairs," between a query amino or nucleic acid sequence and a test sequence which is preferably obtained from a protein or nucleic acid sequence database. Preferably, the statistical significance of a high-scoring segment pair is evaluated using the statistical significance formula (Karlin and Altschul, 1990). The BLAST programs can be used with the default parameters or with modified parameters provided by the user.

"Percentage of sequence identity" is determined by comparing two optimally aligned sequences over a comparison window, where the portion of the polynucleotide sequence in the comparison window may comprise additions or deletions (i.e., gaps) as compared to the reference sequence (which does not comprise additions or deletions) for optimal alignment of the two sequences. The percentage is calculated by determining the number of positions at which the identical nucleic acid base or amino acid residue occurs in both sequences to yield the number of matched positions, dividing the number of matched positions by the total number of positions in the window of comparison, and multiplying the result by 100 to yield the percentage of sequence identity.

The term "substantial identity" of polynucleotide sequences means that a polynucleotide comprises a sequence that has at least 25% sequence identity compared to a reference sequence as determined using the programs described herein; preferably BLAST using standard parameters, as described. Alternatively, percent identity can be any integer from 25% to 100%. More preferred embodiments include polynucleotide sequences that have at least: 25%, 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98% or 99% sequence identity compared to a reference sequence. These values can be appropriately adjusted to determine corresponding identity of proteins encoded by two nucleotide sequences by taking into account codon degeneracy, amino acid similarity, reading frame positioning, and the like. Accordingly, polynucleotides of the present invention encoding a protein of the present invention include nucleic acid sequences that have substantial identity to the nucleic acid sequence of SEQ ID NO:1.

The term "substantial identity" of amino acid sequences (and of polypeptides having these amino acid sequences) normally means sequence identity of at least 40% compared to a reference sequence as determined using the programs described herein; preferably BLAST using standard parameters, as described. Preferred percent identity of amino acids can be any integer from 40% to 100%. More preferred embodiments include amino acid sequences that have at least 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, or 99% sequence identity compared to a reference sequence. Polypeptides that are "substantially identical" share amino acid sequences as noted above except that residue positions which are not identical may differ by conservative amino acid changes. Conservative amino acid substitutions refer to the interchangeability of residues having similar side chains. For example, a group of amino acids having aliphatic side chains is glycine, alanine, valine, leucine, and isoleucine; a group of amino acids having aliphatic-hydroxyl side chains is serine and threonine; a group of amino acids having amide-containing side chains is asparagine and glutamine; a group of amino acids having aromatic side chains is phenylalanine, tyrosine, and tryptophan; a group of amino acids having basic side chains is lysine, arginine, and histidine; and a group of amino acids having sulfur-containing side chains is cysteine and methionine. Preferred conservative amino acids substitution groups are: valine-leucine-isoleucine, phenylalanine-tyrosine, lysine-arginine, alanine-valine, aspartic acid-glutamic acid, and asparagine-glutamine. Accordingly, polypeptides or proteins of the present invention include amino acid sequences that have substantial identity to the amino acid sequence of SEQ ID NO:2.

The invention also relates to nucleic acids that selectively hybridize to the exemplified sequences, including hybridizing to the exact complements of these sequences. The specificity of single-stranded DNA to hybridize complementary fragments is determined by the "stringency" of the reaction conditions (Sambrook et al, 1989). Hybridization stringency increases as the propensity to form DNA duplexes decreases. In nucleic acid hybridization reactions, the stringency can be chosen to favor specific hybridizations (high stringency), which can be used to identify, for example, full-length clones from a library. Less-specific hybridizations (low stringency) can be used to identify related, but not exact (homologous, but not identical), DNA molecules or segments.

DNA duplexes are stabilized by: (1) the number of complementary base pairs; (2) the type of base pairs; (3) salt concentration (ionic strength) of the reaction mixture; (4) the temperature of the reaction; and (5) the presence of certain organic solvents, such as formamide, which decrease DNA duplex stability. In general, the longer the probe, the higher the temperature required for proper annealing. A common approach is to vary the temperature; higher relative temperatures result in more stringent reaction conditions.

To hybridize under "stringent conditions" describes hybridization protocols in which nucleotide sequences at least 60% homologous to each other remain hybridized. Generally, stringent conditions are selected to be about 5.degree. C. lower than the thermal melting point (Tm) for the specific sequence at a defined ionic strength and pH. The Tm is the temperature (under defined ionic strength, pH, and nucleic acid concentration) at which 50% of the probes complementary to the target sequence hybridize to the target sequence at equilibrium. Since the target sequences are generally present at excess, at Tm, 50% of the probes are occupied at equilibrium.

"Stringent hybridization conditions" are conditions that enable a probe, primer, or oligonucleotide to hybridize only to its target sequence (e.g., SEQ ID NO:1). Stringent conditions are sequence-dependent and will differ. Stringent conditions comprise: (1) low ionic strength and high temperature washes, for example 15 mM sodium chloride, 1.5 mM sodium citrate, 0.1% sodium dodecyl sulfate, at 50.degree. C.; (2) a denaturing agent during hybridization, e.g. 50% (v/v) formamide, 0.1% bovine serum albumin, 0.1% Ficoll, 0.1% polyvinylpyrrolidone, 50 mM sodium phosphate buffer (750 mM sodium chloride, 75 mM sodium citrate; pH 6.5), at 42.degree. C.; or (3) 50% formamide. Washes typically also comprise 5.times.SSC (0.75 M NaCl, 75 mM sodium citrate), 50 mM sodium phosphate (pH 6.8), 0.1% sodium pyrophosphate, 5.times.Denhardt's solution, sonicated salmon sperm DNA (50 .mu.g/ml), 0.1% SDS, and 10% dextran sulfate at 42.degree. C., with a wash at 42.degree. C. in 0.2.times.SSC (sodium chloride/sodium citrate) and 50% formamide at 55.degree. C., followed by a high-stringency wash consisting of 0.1.times.SSC containing EDTA at 55.degree. C. Preferably, the conditions are such that sequences at least about 65%, 70%, 75%, 85%, 90%, 95%, 98%, or 99% homologous to each other typically remain hybridized to each other. These conditions are presented as examples and are not meant to be limiting.

"Moderately stringent conditions" use washing solutions and hybridization conditions that are less stringent, such that a polynucleotide will hybridize to the entire, fragments, derivatives, or analogs of the target sequence (e.g., SEQ ID NO:1). One example comprises hybridization in 6.times.SSC, 5.times.Denhardt's solution, 0.5% SDS and 100 .mu.g/ml denatured salmon sperm DNA at 55.degree. C., followed by one or more washes in 1.times.SSC, 0.1% SDS at 37.degree. C. The temperature, ionic strength, etc., can be adjusted to accommodate experimental factors such as probe length. Other moderate stringency conditions have been described (Ausubel et al., 1993; Kriegler, 1990).

"Low stringent conditions" use washing solutions and hybridization conditions that are less stringent than those for moderate stringency, such that a polynucleotide will hybridize to the entire, fragments, derivatives, or analogs of the target sequence (e.g., SEQ ID NO:1). A nonlimiting example of low stringency hybridization conditions includes hybridization in 35% formamide, 5.times.SSC, 50 mM Tris HCl (pH 7.5), 5 mM EDTA, 0.02% PVP, 0.02% Ficoll, 0.2% BSA, 100 .mu.g/ml denatured salmon sperm DNA, 10% (wt/vol) dextran sulfate at 40.degree. C., followed by one or more washes in 2.times.SSC, 25 mM Tris HCl (pH 7.4), 5 mM EDTA, and 0.1% SDS at 50.degree. C. Other conditions of low stringency, such as those for cross-species hybridizations, are well-described (Ausubel et al., 1993; Kriegler, 1990).

When expressed in a plant, the proteins of the present invention confer disease resistance in the plant. The term "disease resistance" refers to any indicia of success in the resistance of disease. A disease resistance response refers to a change in metabolism, biosynthetic activity, or gene expression, which enhances a plant's ability to suppress the replication and spread of a microbial pathogen, i.e., to resist the microbial pathogen. Examples of plant disease defense responses include, but are not limited to, production of low molecular weight compounds with antimicrobial activity (such as phytoalexins) and induction of expression of defense (or defense-related) genes, whose products include, for example, peroxidases, cell wall proteins, proteinase inhibitors, hydrolytic enzymes, pathogenesis-related (PR) proteins and phytoalexin biosynthetic enzymes, such as phenylalanine ammonia lyase and chalcone synthase.

Agents that induce disease defense responses in plants (which are also referred to herein as "disease-causing agents") include, but are not limited to, microbial pathogens such as fungi, bacteria, and viruses. The phrase "useful for conferring disease resistance" refers to the ability to initiate a disease resistance response in a plant and subsequently confer disease resistance in the plant. Transgenic plants of the present invention having enhanced disease resistance have the ability to mount a disease resistance response to disease-causing agents, in particular to oomycete fungi, such as Phytophthora infestans.

The term "disease resistance genes" or "disease resistance proteins" refers to genes or their encoded proteins whose expression or synthesis confers disease resistance. In particular, disease resistance is meant to include late blight resistance.

The nucleic acids and proteins of the present invention may be isolated using methods known in the art. The genes or nucleic acid sequences encoding proteins of the present invention include genes and gene products identified and characterized by analysis using the nucleic acid sequences (including SEQ ID NO:1, SEQ ID NO:3), and protein sequences (including SEQ ID NO:2). Sequences encoding proteins of the present invention include nucleic acid sequences having substantial identity to SEQ ID NO:1. Polypeptides of the present invention include polypeptides having substantial identity to SEQ ID NO:2.

Preferred nucleic acids of the present invention encode proteins involved in disease resistance. Plant disease resistance genes frequently share a leucine-rich repeat (LRR) pattern with or without a nucleotide binding site (NBS). Such NBS-LRR genes may be similar to the Toll interleukin receptor (TIR), or they may lack significant TIR homology (non-TIR) (Ballvora et al., 2002, Plant J. 30: 361-371). Preferred disease resistance genes of the present invention encode polypeptides having 21 LRRs and a NBS domain.

The isolation of gene sequences that can be used in the practice of the present invention may be accomplished by a number of techniques. For instance, oligonucleotide probes based on the sequences disclosed herein can be used to identify the desired gene in a cDNA or genomic DNA library from a desired plant species. To construct genomic libraries, large segments of genomic DNA are generated by random fragmentation, for example using restriction endonucleases, and are ligated with vector DNA to form concatemers that can be packaged into the appropriate vector. The cDNA or genomic library can then be screened using a probe based upon the sequence of a cloned gene such as the polynucleotides disclosed here. Probes may be used to hybridize with genomic DNA or cDNA sequences to isolate homologous genes in the same or different plant species.

Alternatively, the nucleic acids of interest can be amplified from nucleic acid samples using amplification techniques. For instance, polymerase chain reaction (PCR) technology can be used to amplify the sequences of the genes directly from mRNA, from cDNA, from genomic libraries, or from cDNA libraries. PCR and other in vitro amplification methods may also be useful, for example, to clone nucleic acid sequences that code for proteins to be expressed, to make nucleic acids to use as probes for detecting the presence of the desired mRNA in samples, for nucleic acid sequencing, or for other purposes. Appropriate primers and probes for identifying genes encoding a protein of the present invention may be generated from comparisons of the sequences provided herein. For a general overview of PCR see PCR Protocols, 2003, Bartlett and Stirling, eds., 2.sup.nd edition, Humana Press, which is herein incorporated by reference. For examples of primers used see examples section below.

Polynucleotides may also be synthesized by other well-known techniques as described in the literature (Adams et al., 1983, J. Am. Chem. Soc. 105: 661-663). Double-stranded DNA fragments may be obtained either by synthesizing the complementary strand and annealing the strands together under appropriate conditions, or by adding the complementary strand using DNA polymerase with an appropriate primer sequence.

One useful method to produce the nucleic acids of the present invention is to isolate and modify the nucleic acid sequences of the present invention. This can be done using methods of sequence-specific mutagenesis of a nucleic acid, for example oligonucleotide-directed mutagenesis as well as directed mutagenesis of nucleic acids using PCR. Such methods are useful to insert specific codon changes in the nucleic acids of the invention.

Once a nucleic acid is isolated using the methods described above, standard methods can be used to determine if the nucleic acid is a preferred nucleic acid of the present invention and therefore encodes a preferred protein of the present invention, by using structural and functional assays known in the art. For example, the sequence of a putative nucleic acid sequence thought to encode a preferred protein of the present invention can be compared to a nucleic acid sequence encoding a preferred protein of the present invention to determine if the putative nucleic acid is a preferred polynucleotide of the present invention.

Methods of enhancing disease resistance in plants are provided. This can be achieved by, for example, enhancing the expression of polynucleotides of the present invention in transgenic plants. In one embodiment of the invention, disease resistance is enhanced by increasing expression of a gene of the present invention in a plant. Methods of enhancing disease resistance in a plant are provided, which can be practiced by increasing or enhancing expression of the polynucleotide of SEQ ID NO:1 in a plant. A plant with enhanced disease resistance has phenotypic characteristics that are recognizable to the skilled practitioner, e.g., it has normal developmental patterns after exposure to a pathogen or has reduced symptoms following exposure to a pathogen.

Using standard methods, functional assays can be performed to determine if expression or synthesis of the putative genes or proteins confers disease resistance in a plant. For example, the methods of Naess et al., 2000, Theor. App. Genet. 101: 697-701, can be used to screen a transgenic plant containing a putative disease resistance gene of the present invention for late blight resistance. After transformation of a plant cell with a putative polynucleotide of the present invention and subsequent cultivation of the cell to produce a transgenic plant, the resultant transgenic plant and a control plant are sprayed to run-off with a fine mist of P. infestans sporangial suspension or are otherwise inoculated with the pathogen using methods known in the art. A blight scale, with 0 indicating a dead plant and 9 indicating no visible infection, is used to visually rate relative disease severity 4-5, 7, 10-11, and 14-15 days following exposure to P. infestans. The ratings and the ranges of percentage infections associated with the rating value are as follows: 9 equals no visible infection; 8 equals less than 10% infection; 7 equals 11-25% infection; 6 equals 26-40% infection; 5 equals 41-60% infection; 4 equals 61-70% infection; 3 equals 71-80% infection; 2 equals 81-90% infection; 1 equals greater than 90% infection; 0 equals 100% death. A transgenic plant successfully expressing a preferred gene of the present invention will have a higher score on the blight scale than a wild type plant. Such resistant transgenic plant should contain a preferred polynucleotide of the present invention.

A transgenic plant having enhanced or increased expression of a gene identical or substantially identical to a preferred polynucleotide of the present invention, e.g., SEQ ID NO:1, will typically display a phenotype associated with increased disease resistance to a disease-causing agent, such as P. infestans. Phenotypes associated with enhanced disease resistance to disease-causing agents can include, for example, plants with extended photosynthetic life cycles, plants with leaves that stay green for a longer duration of time, plants with an increased yield of fruit or vegetative part (e.g., tuber), plants with larger fruit, flowers, leaves, or stems, plants with improved storage ability of the tuber or other agriculturally or horticulturally significant part, and/or plants substantially lacking in disease symptoms, such as discoloration or lesions on leaves, stems, or tubers, as compared to a wild type plant, following exposure to a disease-causing agent.

Using specific promoters, the expression of a gene of the present invention can be temporally and/or spatially directed, and various types of plants with enhanced resistance to Phytophthora infestans can be created. For example, in some embodiments of the present invention, a tissue-specific promoter can be used to create a transgenic plant with increased resistance to Phytophthora infestans. The targeted tissue may be potato tuber and the tuber-specific promoter may be preferentially driving expression of the transgene in the potato tuber. Similarly, it is possible to choose from a variety of known promoters, whether constitutive, inducible, developmentally-regulated, tissue-specific, and the like, to drive expression of the polynucleotides of the present invention, thereby enhancing disease resistance in plants. Examples of useful promoters are described below. The sequences described herein can be used to prepare expression cassettes that enhance or increase endogenous or exogenous gene expression.

Any phenotypic characteristic caused by an alteration of disease resistance in a plant, for example enhanced resistance, can be selected for in the present invention. In one embodiment, after introducing a polynucleotide of the present invention operably linked to a desirable promoter (e.g., constitutive, tissue-specific, or inducible) in a plant and regenerating the plant by standard procedures, standard methods can be used to determine if the transgenic plant is a transgenic plant of the present invention, e.g., by comparing the transgenic plant to a wild type plant after exposure to a plant pathogen and looking for phenotypes associated with an alteration of disease resistance, e.g., reduced number and/or reduced size of lesions on the affected plant part.

Enhancing or increasing expression of a gene of the present invention in a plant may modulate disease resistance processes by a variety of pathways. The particular pathway used to modulate disease resistance is not critical to the present invention.

Any number of means well known in the art can be used to increase activity of a gene of the present invention in a plant. Any organ can be targeted for overexpression of a protein of the present invention, such as shoot vegetative organs/structures (e.g., leaves, stems, and tubers), roots, flowers, and floral or reproductive organs/structures (e.g., bracts, sepals, petals, stamens, carpels, anthers and ovules), seed (including embryo, endosperm, and seed coat), and fruit. Vascular or provascular tissues may be targeted. Alternatively, one or several genes described in the present invention may be expressed constitutively (e.g., using the CaMV 35S promoter).

The polypeptides encoded by the genes of the invention, like other proteins, have different domains which perform different functions. Thus, the gene sequences need not be full length, so long as the desired functional domain of the protein is expressed. If proper polypeptide expression is desired, a polyadenylation region at the 3'-end of the coding region may be included. The polyadenylation region can be derived from the natural gene, from a variety of other plant genes, or from T-DNA.

Vectors useful for practicing the present invention can be prepared using methods known in the art. Typical vectors contain transcription and translation terminators, transcription and translation initiation sequences, and promoters useful for regulation of the expression of the particular nucleic acid. The vectors optionally comprise generic expression cassettes containing at least one independent terminator sequence, sequences permitting replication of the cassette in eukaryotes, or prokaryotes, or both, (e.g., shuttle vectors) and selection markers for both prokaryotic and eukaryotic systems. Vectors may be suitable for replication and integration in prokaryotes, eukaryotes, or preferably both. Numerous vectors, bacteria, and bacteriophages that are useful for cloning may be obtained from the American Type Culture Collection (ATCC), Manassas, Va. Additional procedures for sequencing, cloning and other aspects of molecular biology and underlying theoretical considerations are also found in Watson et al., 1992, Recombinant DNA, Second Edition, W.H. Freeman & Co., New York, N.Y., which is herein incorporated by reference.

To use isolated sequences in the above techniques, recombinant DNA vectors suitable for transformation of plant cells are prepared. Techniques for transforming a wide variety of higher plant species are well known and described in the scientific literature, for example in Weising et al., 1988, Annu. Rev. Genet. 22: 421-477; and in Chrispeels et al., 2003, Plants, Genes, and Crop Biotechnology, Second Ed., James and Bartlett Publishers, Sudbury, Mass., both of which are incorporated herein by reference. A DNA sequence coding for the desired polypeptide, for example a cDNA sequence encoding a full length protein, will preferably be combined with transcriptional and translational initiation regulatory sequences that will direct the transcription of the sequence from the gene in the intended tissues of the transformed plant.

Alternatively, the plant promoter may direct expression of the polynucleotide of the invention in a specific tissue (tissue-specific promoters), organ (organ-specific promoters), may be regulated during various developmental stages (developmentally-regulated promoters), or may be otherwise under more precise environmental control (inducible promoters). The above categories are not exclusive, as promoters may have various modes of temporal, spatial, and developmental regulation (e.g., both tissue specificity and developmental control). A tissue-specific promoter may drive expression of operably linked sequences in tissues other than the target tissue. Thus, a tissue-specific promoter is one that drives expression preferentially in the target tissue, but may also lead to some expression in other tissues as well. Examples of tissue-specific promoters under developmental control include promoters that initiate transcription at certain times only in certain tissues, such as fruit, seeds, flowers, pistils, or anthers. Examples of environmental conditions that may affect transcription by inducible promoters include anaerobic conditions, elevated temperature, or the presence of light.

The vector comprising the sequences (e.g., promoters or coding regions) from genes of the invention will typically comprise a marker gene that confers a selectable phenotype on plant cells. For example, the marker may encode biocide resistance, particularly antibiotic resistance, such as resistance to kanamycin, G418, bleomycin, hygromycin, or herbicide resistance, such as resistance to chlorosulfuron or Basta. Alternatively, materials and methods for producing transgenic plants containing only desired foreign genes and which are free of unwanted or irrelevant selection genes are disclosed in International Patent Application Publication No. WO/1993/001283.

Nucleic acid sequences of the present invention can be expressed recombinantly in plant cells to enhance and increase levels of endogenous plant transcription factors. A variety of different expression constructs, such as expression cassettes and vectors suitable for transformation of plant cells, can be prepared. A DNA sequence coding for a polypeptide described in the present invention can be combined, for example, with cis-acting (promoter and enhancer) transcriptional regulatory sequences to direct the timing, tissue type and levels of transcription in the intended tissues of the transformed plant. Translational control elements can also be used.

The invention provides a nucleic acid operably linked to a promoter which, in some embodiments, is capable of driving the transcription of the coding sequence in plants. The promoter can be typically derived from plant or viral sources. In construction of recombinant expression cassettes, vectors, transgenics, of the invention, different promoters can be chosen and employed to differentially direct gene expression, e.g., in some or all tissues. Typically, desired promoters are identified by analyzing the 5' sequences of a genomic clone corresponding to the genes described.

In one embodiment, a promoter or promoter fragment can be employed which will direct expression of a nucleic acid of the present invention in all transformed cells or tissues, for example as those of a regenerated plant. Such promoters are referred to herein as "constitutive" promoters and are active under most environmental conditions and states of development or cell differentiation. Examples of constitutive promoters include those from viruses which infect plants, such as the cauliflower mosaic virus (CaMV) 35S transcription initiation region (Dagless, 1997, Arch. Virol. 142: 183-191); the 1'- or 2'-promoter derived from T-DNA of Agrobacterium tumefaciens (O'Grady, 1995, Plant Mol. Biol. 29: 99-108); the promoter of the tobacco mosaic virus; the promoter of Figwort mosaic virus (Maiti, 1997, Transgenic Res. 6: 143-156); actin promoters, such as the Arabidopsis actin gene promoter (Huang, 1997, Plant Mol. Biol. 33: 125-139); alcohol dehydrogenase (Adh) gene promoters (Millar, 1996, Plant Mol. Biol. 31: 897-904); ACT11 from Arabidopsis (Huang et al., 1996, Plant Mol. Biol. 33: 125-139), Cat3 from Arabidopsis (Zhong et al., 1996, Mol. Gen. Genet. 251: 196-203), the gene encoding stearoyl-acyl carrier protein desaturase from Brassica napus (Solocombe et al., 1994, Plant Physiol. 104: 1167-1176), GPc1 from maize (Martinez et al., 1989, J. Mol. Biol. 208: 551-565), Gpc2 from maize (Manjunath et al., 1997, Plant Mol. Biol. 33: 97-112), and other transcription initiation regions from various plant genes (Holtorf, 1995, Plant Mol. Biol. 29: 637-646).

A plant promoter can direct expression of the nucleic acids described in the present invention under the influence of changing developmental conditions. Examples of developmental conditions that may affect transcription by inducible promoters include senescence and embryogenesis. Such promoters are referred to herein as "developmentally-regulated" promoters. For example, the invention incorporates the senescence-inducible promoter SAG 12 of Arabidopsis (Gan and Amasino, 1995, Science 270: 1986-1988) and the embryogenesis-related promoters of LEC1 (Lotan et al., 1998, Cell 93: 1195-1205), LEC2 (Stone et al., 2001, Proc. Natl. Acad. Sci. USA 98: 11806-11811), FUS3 (Luerssen, 1998, Plant J. 15: 755-764), AtSERK1 (Hecht et al., 2001, Plant Physiol. 127: 803-816), AGL15 (Heck et al., 1995, Plant Cell 7: 1271-1282), and BBM (BABYBOOM) (Boutilier et al., 2002, Plant Cell 14: 1737-1749).

A plant promoter can direct expression of the nucleic acids described in the present invention under the influence of changing environmental conditions. Examples of environmental conditions that may effect transcription by inducible promoters include anaerobic conditions, elevated temperature, drought, or the presence of light. Such promoters are referred to herein as "inducible" promoters, as it is possible to induce and/or increase gene transcription by manipulating the environmental conditions. For example, the invention incorporates the drought-inducible promoter of maize (Busk, 1997, Plant J. 11: 1285-1295); and the cold-, drought-, and high salt-inducible promoter from potato (Kirch, 1997, Plant Mol. Biol. 33: 897-909); in such cases, by creating drought and/or cold or high salt conditions, it is possible to express the nucleic acids of this invention. Alternatively, plant promoters which are inducible upon exposure to plant hormones, such as auxins or cytokinins, can be used to express the nucleic acids of this invention. The invention can use the auxin response elements E1 promoter fragment (AuxREs) from soybean (Liu, 1997, Plant Physiol. 115: 397-407); the auxin-responsive Arabidopsis GST6 promoter (also responsive to salicylic acid and hydrogen peroxide) (Chen, 1996, Plant J. 10: 955-966); the auxin-inducible parC promoter from tobacco (Sakai, 1996, 37: 906-913); a plant biotin response element (Streit, 1997, Mol. Plant Microbe Interact. 10: 933-937); and the promoter responsive to the stress hormone abscisic acid (Sheen, 1996, Science 274: 1900-1902). The invention can also use the cytokinin-inducible promoters of ARR5 and ARR6 (Brandstatter and Kieber, 1998, Plant Cell 10: 1009-1019), ARR2 (Hwang and Sheen, 2001, Nature 413: 383-389), the ethylene-responsive promoter of ERF1 (Solano et al., 1998, Genes Dev. 12: 3703-3714), and the .beta.-estradiol-inducible promoter of XVE (Zuo et al., 2000, Plant J. 24: 265-273).

Plant promoters which are inducible upon exposure to chemical reagents that can be applied to the plant, such as herbicides or antibiotics, are also used to express the nucleic acids of the invention. For example, the maize In2-2 promoter, activated by benzenesulfonamide herbicide safeners, can be used (De Veylder, 1997, Plant Cell Physiol. 38: 568-577) as well as the promoter of the glucocorticoid receptor protein fusion inducible by dexamethasone application (Aoyama, 1997, Plant J. 11: 605-612); application of different herbicide safeners induces distinct gene expression patterns, including expression in the root, hydathodes, and the shoot apical meristem. The coding sequence of the described nucleic acids can be under the control of a tetracycline-inducible promoter, for example as described with transgenic tobacco plants containing the Avena sativa L. (oat) arginine decarboxylase gene (Masgrau, 1997, Plant J. 11: 465-473); or it can also be under the control of a salicylic acid-responsive element (Stange, 1997, Plant J. 11: 1315-1324).

Alternatively, inducible promoters include the tetracycline repressor/operator controlled promoter, the heat shock gene promoters, stress (e.g., wounding)-inducible promoters, defense responsive gene promoters (e.g., phenylalanine ammonia lyase genes), wound induced gene promoters (e.g., hydroxyproline rich cell wall protein genes), chemically-inducible gene promoters (e.g., nitrate reductase genes, glucanase genes, chitinase genes, etc.) and dark-inducible gene promoters (e.g., asparagine synthetase gene). Pathogen-inducible and wound-inducible promoters include, but are not limited, to promoters of genes encoding lipoxygenases (Peng et al., 1994, J. Biol. Chem. 269: 3755-3761); promoters of genes encoding peroxidases (Chittoor et al., 1997, Mol. Plant-Microbe Interactions 10: 861-871); promoters of genes encoding hydroxymethylglutaryl-CoA reductase (Nelson et al., 1994, Plant Mol. Biol. 25: 401-412); promoters of genes encoding phenylalanine ammonia lyase (Yamada et al., 1994, Plant Cell Physiol. 35: 917-926); promoters of genes encoding glutathione-S-transferase; promoters from genes encoding chitinases (Zhu and Lamb, 1991, Mol. Gen. Genet. 226: 289-296); promoters from plant viral genes, either contained on a bacterial plasmid or on a plant viral vector (Hammond-Kosack et al., 1994, Mol. Plant-Microbe Interactions 8: 181-185); promoters from genes involved in the plant respiratory burst (Groom et al., 1996, Plant J. 10: 515-522); and promoters from plant anthocyanin pathway genes (Quattrochio et al., 1993, Plant Cell 5: 1497-1512).

The plant promoter can direct expression of the polynucleotide of the invention in a specific tissue. Such promoters are referred to herein as "tissue-specific promoters". The tissue-specific promoters are transcriptional control elements that are only active in particular cells or tissues at specific times during plant development, such as in vegetative tissues or reproductive tissues. Examples of tissue-specific promoters under developmental control include promoters that initiate transcription only (or primarily only) in certain tissues, such as vegetative tissues, e.g., roots, leaves or stems, or reproductive tissues, such as fruit, ovules, seeds, pollen, pistils, flowers, or any embryonic tissue. Reproductive tissue-specific promoters can be, e.g., ovule-specific, embryo-specific, endosperm-specific, integument-specific, seed and seed coat-specific, pollen-specific, petal-specific, sepal-specific, or some combination thereof.

Suitable seed-specific promoters may be derived from the following genes: MAC1 from maize (Sheridan, 1996, Genetics 142: 1009-1020); Cat3 from maize (Abler, 1993, Plant Mol. Biol. 22: 10131-1038); viviparous-1 from Arabidopsis (Suzuki et al., 2003, Plant Physiology 132: 1664-1667); atmyci from Arabidopsis (Urao, 1996, Plant Mol. Biol. 32: 571-57); napA and BnCysP1 from Brassica napus (Wan et al., 2002, Plant J. 30:1-10); and the napin gene family from Brassica napus (Sjodahl, 1995, Planta 197: 264-271). Fruit-specific promoters include the promoter from the CYP78A9 gene (Ito and Meyerowitz, 2000, Plant Cell 12: 1541-1550).

The ovule-specific BELL gene described in Reiser, 1995, Cell 83: 735-742, GenBank No. U39944, can also be used (Ray, 1994, Proc. Natl. Acad. Sci. USA 91: 5761-5765). The egg and central cell specific FIE1 promoter is also a useful reproductive tissue-specific promoter.

Sepal and petal specific promoters can also used be to express nucleic acids in a reproductive tissue-specific manner. For example, the Arabidopsis floral homeotic gene APETALA1 (AP1) encodes a putative transcription factor that is expressed in young flower primordia, and later becomes localized to sepals and petals (Gustafson-Brown, 1994, Cell 76: 131-143). A related promoter, for AP2, a floral homeotic gene that is necessary for the normal development of sepals and petals in floral whorls, is also useful (Drews, 1991, Cell 65: 991-1002). Another useful promoter is that controlling the expression of the unusual floral organs (ufo) gene of Arabidopsis, whose expression is restricted to the junction between sepal and petal primordia (Bossinger, 1996, Development 122: 1093-1102). A pollen-specific promoter that has been identified in maize (Guerrero, 1990, Mol. Gen. Genet. 224: 161-168) can also be used.

Promoters specific for pistil and silique valves, inflorescence meristems, cauline leaves, and the vasculature of stem and floral pedicels include promoters from the FUL gene (Mandel and Yanofsky, 1995, Plant Cell 7: 1763-1771). Promoters specific for developing carpels, placenta, septum, and ovules, may also used to express nucleic acids of the present invention in a tissue-specific manner. They include promoters from the SHP1 and SHP2 genes (Flanagan et al., 1996, Plant J. 10: 343-353). The pistil specific promoter in the potato (Solanum tuberosum) SK2 gene, encoding a pistil specific basic endochitinase (Ficker, 1997, Plant Mol. Biol. 35: 425-431), can also be used.

Other suitable promoters include those from genes encoding embryonic storage proteins. For example, the gene encoding the 2S storage protein from Brassica napus (Dasgupta, 1993, Gene 133: 301-302); the gene encoding oleosin 20 kD from Brassica napus (GenBank No. M63985); the genes encoding oleosin A (GenBank No. U09118) and oleosin B (GenBank No. U09119) from soybean; the gene encoding oleosin from Arabidopsis (GenBank No. Z17657); the gene encoding oleosin 18 kD from maize (Lee, 1994, Plant Mol. Biol. 26: 1981-1987); and the gene encoding low molecular weight sulphur rich protein from soybean (Choi, 1995, Mol Gen. Genet. 246: 266-268), can be used. The tissue-specific E8 promoter from tomato is particularly useful for directing gene expression so that a desired gene product is located in fruits. Suitable promoters may also include those from genes expressed in vascular tissue, such as the ATHB-8, AtPIN1, AtP5K1, or TED3 genes (Baima et al., 2001, Plant Physiol. 126: 643-655; Galaweiler et al., 1998, Science 282: 2226-2230); Elge et al., 2001, Plant J. 26: 561-571; Igarashi et al., 1998, Plant Mol. Biol. 36: 917-927).

A variety of promoters specifically active in vegetative tissues, such as leaves, stems, roots and tubers, can also be used to express the nucleic acids used in the methods of the invention. For example, promoters controlling patatin, the major storage protein of the potato tuber (Martin, 1997, Plant J. 11: 53-62), can be used. The ORF13 promoter from Agrobacterium rhizogenes which exhibits high activity in roots can also be used (Hansen, 1997, Mol. Gen. Genet. 254: 337-343). Other useful vegetative tissue-specific promoters include: the tarin promoter of the gene encoding a globulin from a major taro (Colocasia esculenta L. Schott) corn protein family, tarin (Bezerra, 1995, Plant Mol. Biol. 28: 137-144); the curculin promoter active during taro corm development (de Castro, 1992, Plant Cell 4: 1549-1559), and the promoter for the tobacco root specific gene TobRB7, whose expression is localized to root meristem and immature central cylinder regions (Yamamoto, 1991, Plant Cell 3: 371-382).

Leaf-specific promoters, such as the ribulose biphosphate carboxylase/oxygenase small subunit ("RuBisCO") promoter, can be used. For example, the tomato RuBisCO RBCS1, RBCS2 and RBCS3A genes are expressed in leaves and light grown seedlings, only RBCS1 and RBCS2 are expressed in developing tomato fruits (Meier et al., 1997, FEBS Lett. 415: 91-95). Another leaf-specific promoter is the light harvesting chlorophyll a/b binding protein gene promoter (Casal, 1998, Plant Physiol. 116: 1533-1538). The Arabidopsis thaliana myb-related gene promoter (Atmyb5) described by Li et al., 1996, FEBS Lett. 379: 117-121, is leaf-specific, and is expressed in developing leaf trichomes, stipules, and epidermal cells on the margins of young rosette and cauline leaves, and in immature seeds. A leaf promoter identified in maize by Busk et al., 1997, Plant J. 11: 1285-1295, can also be used.

Another class of useful vegetative tissue-specific promoters are meristematic (root tip and shoot apex) promoters. For example, the "SHOOTMERISTEMLESS" and "SCARECROW" promoters, which are active in the developing shoot or root apical meristems, can be used (Di Laurenzio et al., 1996, Cell 86: 423-433; Long et al., 1996, Nature 379: 66-69). Another useful promoter is that which controls the expression of 3-hydroxy-3-methylglutaryl coenzyme A reductase HMG2 gene, whose expression is restricted to meristematic and floral (secretory zone of the stigma, mature pollen grains, gynoecium vascular tissue, and fertilized ovules) tissues (Enjuto, 1995, Plant Cell 7: 517-527). Also useful are kn1-related genes from maize and other species which show meristem-specific expression (Granger, 1996, Plant Mol. Biol. 31: 373-378; Kerstetter, 1994, Plant Cell 6: 1877-1887). Similarly, the KNAT1 promoter from Arabidopsis thaliana, whose transcript is localized primarily to the shoot apical meristem and to the inflorescence stem cortex, can be used (Lincoln, 1994, Plant Cell 6: 1859-1876).

The invention also provides for use of tissue-specific promoters derived from viruses, which can include, for example, the tobamovirus subgenomic promoter (Kumagai, 1995, Proc. Natl. Acad. Sci. USA 92: 1679-1683), the rice tungro bacilliform virus (RTBV), which drives strong phloem-specific reporter gene expression; the cassaya vein mosaic virus (CVMV) promoter, with highest activity in vascular elements, in leaf mesophyll cells, and in root tips (Verdaguer, 1996, Plant Mol. Biol. 31: 1129-1139).

In another embodiment, a nucleic acid described in the present invention is expressed through a transposable element. This allows for constitutive, yet periodic and infrequent expression of the desired polypeptide.

Native promoters from Solanum verrucosum are provided. In particular, disease resistance promoters from Solanum verrucosum are provided, which are capable of controlling expression of the genes of the present invention. A disease resistance promoter from Solanum verrucosum is a promoter derived from a Solanum verrucosum disease resistance gene, for example by cloning, isolating, or modifying a native promoter from a disease resistance gene. The provided promoters can be used to initiate gene expression in a plant cell.

Preferred promoters of the present invention can control expression of the RB.sup.ver gene. Accordingly, the preferred promoters can control expression of genes comprising coding regions that have substantial identity to the coding region of SEQ ID NO:1, for example genes that have at least 70%, 80%, 90%, 95%, 95%, 97%, 98%, 99%, or 100% identity to the coding regions of SEQ ID NO:1.

A promoter sequence of the present invention can be identified, for example, by analyzing the 5', or in some instances 3', region of a genomic clone corresponding to the disease resistance genes described herein. Sequence characteristic of promoter sequences can be used to identify the promoter. Sequences controlling eukaryotic gene expression have been extensively studied. For instance, promoter sequence elements include the TATA box consensus sequence, which is upstream of the transcription start site. In most instances the TATA box is required for accurate transcription initiation. In plants, further upstream from the TATA box, there may also be a CCAAT box, and/or additional promoter elements that are required for full promoter activity. A number of methods are known for identifying and characterizing promoter regions in plant genomic DNA (An et al., 1986, Mol. Gen. Genetics 203: 245-250; Jordano et al., 1989, Plant Cell 1: 855-866; Meier et al., 1991, Plant Cell 3: 309-316; Zhang et al., 1996, Plant Physiology 110: 1069-1079).

Transgenic plants comprising expression cassettes or vectors, which include a Solanum verrucosum promoter operably linked to a nucleic acid of the present invention, are also provided. The promoters and nucleic acids can be operably linked using standard recombinant techniques. The promoter may be homologous or heterologous to the nucleic acid. Preferably, expression of the nucleic acids of the present invention under the control of the promoter will increase survival of the plant in response to infection with a microbial pathogen, and in particular, in response to P. infestans. Promoter activity can be measured, for example, by measuring the difference upon contact or infection with a pathogen such as P. infestans in mRNA transcribed by genes under the control of the promoter, in comparison to untransformed control plants.

Transgenic plants of the present invention can be prepared using methods known in the art. DNA constructs of the invention may be introduced into the genome of a desired plant host by a variety of conventional techniques. For example, the DNA construct may be introduced directly into the genomic DNA of the plant cell using techniques such as microinjection and electroporation of plant cell protoplasts, or the DNA constructs can be introduced directly into plant tissue using biolistic methods, such as DNA particle bombardment. Plant cell microinjection techniques are known in the art and well described in the scientific and patent literature, for example in U.S. Pat. No. 4,743,548. The introduction of DNA constructs using polyethylene glycol precipitation is described in Paszkowski et al., 1984, EMBO J. 3: 2717-2722. Electroporation techniques are described in Fromm et al., 1985, Proc. Natl. Acad. Sci. USA 82: 5824-5828. Biolistic transformation techniques are described in Klein et al., 1987, Nature 327: 70-73. Alternatively, the DNA constructs may be combined with suitable T-DNA flanking regions and introduced into a conventional Agrobacterium tumefaciens host vector. The virulence functions of the Agrobacterium tumefaciens host will direct the insertion of the construct and adjacent marker into the plant cell DNA when the cell is infected by the bacteria. Agrobacterium tumefaciens-mediated transformation techniques, including disarming and use of binary vectors, are well described in the scientific literature (Horsch et al, 1984, Science 233: 496-498; Gelvin, 2003, Microb. Mol. Biol. Reviews 67:16-37). Other species of bacteria outside the Agrobacterium genus can also be used for gene transfer into plants (Broothaerts et al., 2005, Nature 433: 629-633).

Transformed plant cells which are derived by any of the above transformation techniques can be cultured to regenerate a whole plant which possesses the transformed genotype and thus the desired phenotype. Regeneration techniques rely on manipulation of certain phytohormones in a tissue culture growth medium, typically relying on a biocide and/or herbicide marker which has been introduced together with the desired nucleotide sequences. Plant regeneration from cultured protoplasts is described in Binding, 1985, Regeneration of Plants, Plant Protoplasts, pp. 21-73, CRC Press, Boca Raton, Fla., which is herein incorporated by reference. Regeneration can also be obtained from plant callus, explants, organs, or parts thereof. Such regeneration techniques are described generally in Klee et al., 1987, Annu. Rev. Plant Physiol. 38: 467-486.

The nucleic acids of the invention can be used to confer desired traits, i.e., to confer disease resistance, on essentially any plant. Thus, the invention has use over a broad range of plants, monocots and dicots, including species from the genera Asparagus, Atropa, Avena, Brassica, Citrus, Citrullus, Capsicum, Cucumis, Cucurbita, Daucus, Fragaria, Glycine, Gossypium, Helianthus, Heterocallis, Hordeum, Hyoscyamus, Lactuca, Linum, Lolium, Lycopersicon, Malus, Manihot, Majorana, Medicago, Nicotiana, Oryza, Panieum, Pannesetum, Persea, Pisum, Pyrus, Prunus, Raphanus, Secale, Senecio, Sinapis, Solanum, Sorghum, Trigonella, Triticum, Vitis, Vigna, and Zea. Examples include tobacco and Arabidopsis, cereal crops such as maize, wheat, rice, soybean barley, rye, oats, sorghum, alfalfa, clover and the like, oil-producing plants such as canola, safflower, sunflower, peanut and the like, vegetable crops such as tomato tomatillo, potato, pepper, eggplant, sugar beet, carrot, cucumber, lettuce, pea and the like, horticultural plants such as aster, begonia, chrysanthemum, delphinium, zinnia, lawn and turfgrasses and the like.

The disease resistance genes and proteins of the present invention are particularly useful for conferring disease resistance in solanaceous plants, such as plants of the Solanaceae family, in particular in the genus Solanum, and further in particular in the cultivated variety of potato, Solanum tuberosum. Additional examples of solanaceous plants include eggplant, potato, tomato, and the like. In some embodiments, the disease resistance genes and proteins of the present invention are useful for conferring disease resistance in any plant infected by a Phytophthora species including, but not limited to, grape plants, avocado plants, and fruit and nut tree varieties. In particular, the transgenic plants expressing the genes and proteins of the present invention exhibit enhanced disease resistance to Phytophthora infestans.

In one example, after introduction of the expression cassette into a plant, the plants are screened for the presence of the transgene and crossed to an inbred or hybrid line. Progeny plants are then screened for the presence of the transgene and self-pollinated. Progeny from the self-pollinated plants are grown. The resultant transgenic plants can be examined for any of the phenotypic characteristics associated with altered disease resistance characteristics, for example healthier leaves following exposure to a pathogen. Using the methods of the present invention, overexpression of the nucleic acids and/or proteins described in the present invention is used to enhance disease resistance. Standard methods can be used to determine if a plant possesses the characteristics associated with enhanced disease resistance. For example, a late blight scoring system can be used to determine if a plant has enhanced resistance to Phytophthora infestans. In a preferred embodiment, the transgenic plants have enhanced disease resistance to late blight. Transgenic plants transformed with the RB gene can be tested, recording foliage blight scores 69, 92, 116, and 163 hours after inoculation. The average resistant score for transgenic plants with the RB gene is then determined, and is compared to the average resistant score of untransformed control plants.

Using known procedures, screens for plants of the invention can be performed by detecting increased or decreased levels of the claimed gene and claimed protein in a plant and detecting the desired phenotype. Means for detecting and quantifying mRNA or proteins are well known in the art, such as Northern blots, RT-PCR, DNA microarrays, Western blots, or protein activity assays. Gene amplification and/or expression can be measured in a sample directly, for example, by conventional Southern blotting, Northern blotting to quantitate the transcription of mRNA, dot blotting (DNA analysis), DNA microarrays, or in situ hybridization, using an appropriately labeled probe, based on the sequences provided herein. Various labels can be employed, most commonly radioisotopes, particularly .sup.32P. However, other techniques can also be employed, such as using biotin-modified nucleotides for introduction into a polynucleotide. The biotin then serves as the site for binding to avidin or antibodies, which can be labeled with a wide variety of labels, such as radionuclides, fluorescers, enzymes, or the like. Alternatively, antibodies can be employed that can recognize specific duplexes, including DNA duplexes, RNA duplexes, and DNA-RNA hybrid duplexes, or DNA-protein duplexes. The antibodies in turn can be labeled and the assay can be carried out where the duplex is bound to a surface, so that upon the formation of duplex on the surface, the presence of antibody bound to the duplex can be detected. Gene expression, alternatively, can be measured by immunological methods, such as immunohistochemical staining. With immunohistochemical staining techniques, a cell sample is prepared, typically by dehydration and fixation, followed by reaction with labeled antibodies specific for the gene product coupled, where the labels are usually visually detectable, such as enzymatic labels, fluorescent labels, luminescent labels, and the like. Gene expression can also be measured using DNA microarrays, commonly known as gene chips.

Provided are antibodies immunologically specific for all or part, e.g., an amino-terminal portion, of polypeptides of the present invention. The term "antibodies" as used herein includes polyclonal and monoclonal antibodies, chimeric, and single chain antibodies, as well as Fab fragments, including the products of a Fab or other immunoglobulin expression library. With respect to antibodies, the term "immunologically specific" refers to antibodies that bind to one or more epitopes of a protein of interest, but which do not substantially recognize and bind other molecules in a sample containing a mixed population of antigenic biological molecules. Antibodies immunologically specific for part or all of the polypeptides of the present invention, e.g., SEQ ID NO:2 or a fragment thereof, are provided as well. For example, the antibodies may be immunologically specific for polypeptides that are at least 80% identical to a sequence as shown in SEQ ID NO:2, or they may be immunologically specific for polypeptides that are at least 90% identical to a sequence as shown in SEQ ID NO:2. The antibodies may be immunologically specific for all or part, e.g., an amino-terminal portion, of an RB polypeptide encoded by an isolated nucleic acid that hybridizes under stringent conditions to a sequence as shown in SEQ ID NO:1 or the complement thereof. Accordingly, isolated antibodies or antibody compositions that specifically bind to a polypeptide having the amino acid sequence as shown in SEQ ID NO:2 are provided. In some embodiments, the antibodies may be monoclonal. Alternatively, the antibodies may be polyclonal. The antibodies of the present invention may be labeled using methods known in the art. A "label" is a composition detectable by various means, for example by spectroscopic, photochemical, biochemical, immunochemical, or chemical means. Useful labels include .sup.32P, fluorescent dyes, electron-dense reagents, enzymes (e.g., as commonly used in an ELISA), biotin, digoxigenin, or proteins for which antisera or monoclonal antibodies are available.

Also provided are methods of detecting RB polypeptides in a sample, by way of contacting the sample with an anti-RB antibody of the present invention, and subsequently determining whether a hybridization complex has been formed between the antibody and the polypeptide.

The polypeptides of the present invention may be used alone or in combination with other proteins or agents to enhance disease resistance. Other agents to enhance disease resistance include, for example, fungicides.

It is to be understood that this invention is not limited to the particular methodology, protocols, subjects, or reagents described, and as such may vary. It is also to be understood that the terminology used herein is for the purpose of describing particular embodiments only, and is not intended to limit the scope of the present invention, which is limited only by the claims. The following examples are offered to illustrate, but not to limit the claimed invention.

EXAMPLES

Phytophthora infestans Strains and Culture Conditions

Phytophthora infestans isolate US 940480 (A2 mating type, race 0.1.2.3.4.5.6.7.10.11) was obtained from Barbara Baker (USDA/ARS, Albany, Calif.). P. infestans isolates were routinely cultured at 15.degree. C. on rye A agar medium supplemented with 2% sucrose (Caten and Jinks, 1968, Can. J. Bot. 46: 329-347). Washes using sterile distilled water were combined to obtain a sporangia count of the desired concentration. Sporangial suspensions were placed at 12.degree. C. for 1.5 to 3 hours to induce zoospore hatching.

Plant Growth Conditions

Seeds for S. verrucosum accessions (PI numbers 161173, 275256, 275258, 275260, 310966, 365404, 558485, and 570643) were obtained from the National Research Support Program-6 (NRSP-6) potato genebank in Sturgeon Bay, Wisconsin. Seedlings were grown under greenhouse conditions (23.degree. C. day/15.degree. C. night temperatures with 14 hours of light) and watered as needed.

Preparation of Genomic DNA and RNA

Potato genomic DNA was isolated from leaves of the eight S. verrucosum accessions described herein according to Dellaporta et al., 1983, Mol. Biol. Rep. 1: 19-21. DNA samples were checked for purity and integrity using spectrophotometry and gel electrophoresis. Total RNA was extracted from young leaves of the eight S. verrucosum accessions using the GenElute.TM. Total RNA Purification Kit (Sigma-Aldrich, St. Louis, Mo.). Contaminating DNA was removed from the RNA preparations using TURBO DNA-Free.TM. (Applied Biosystems/Ambion, Austin, Tex.). The concentration and quality of RNA samples were determined using an Experion.TM. RNA HighSens Analysis Kit (Bio-Rad Laboratories, Hercules, Calif.).

Primer Design, PCR Amplification, and Reverse Transcription-PCR Analyses

Total genomic DNA was extracted from eight S. verrucosum accessions: PI161173; PI 275256; PI 275258; PI 275260; PI 310966; PI 365404; PI 558485; PI 570643. DNA samples were checked for purity and integrity using spectrophotometry.

A pair of oligonucleotide primers--F1, which is 5'-CTT CCC ATT TCA TTC CAA CTA GCC-3' (SEQ ID NO:4) and R14, which is 5'-CCT TCT CAC ACC GCT TGA TCA G-3' (SEQ ID NO:5)--were designed for the amplification of a 3624 nt fragment of the S. bulbocastanum RB gene. PCR amplification was performed on total genomic DNA from the eight S. verrucosum accessions using Platinum.RTM. PCR SuperMix High Fidelity (Invitrogen, Carlsbad, Calif.). The PCR conditions were: 1 min at 94.degree. C. followed by 40 cycles of 15 sec at 94.degree. C., 30 sec at 52.degree. C., 5 min at 68.degree. C., and 15 min at 68.degree. C. The PCR products were purified using the Wizard.RTM. SV Gel and PCR Clean-Up System (Promega, Madison, Wis.) and ligated into the pGEM.RTM.-T Easy Vector (Promega) before cloning and sequence analysis. The PCR product amplified from S. verrucosum accession PI 275260 was digested with NotI and ligated into the NotI site of the pBluescript KS+ vector. It was then cut with BamHI and SacI and ligated into BamHI and SacI digested binary vector pBI121 (Clontech, Mountain View, Calif.).

Reverse transcription (RT) PCR was carried out using the SuperScript.TM. III First-Strand Synthesis System for RT-PCR (Invitrogen) followed by PCR amplification of the first-strand cDNA product using primer pairs: F3, which is 5'-TCA AGC CGT CCT TGA AGA TGC TCA G-3' (SEQ ID NO:6); and R3, which is 5'-GGC GAA ACC AAT GGA CAT CAT ATG-3' (SEQ ID NO:7). The PCR products were purified using Wizard.RTM. SV Gel and PCR Clean-Up System (Promega).

Full Length RB-Orthologous Gene Construction

In one example, a fragment amplified from S. verrucosum did not encode the complete C-terminal of the polypeptide. Therefore, a complete open reading frame of RB.sup.ver from accession PI 275260 was constructed using splicing by overlap extension (SOE) of the S. verrucosum and S. bulbocastanum RB genes. One 3962 bp intermediate fragment was amplified from S. verrucosum accession PI 275260 in pBI121 using the primers 35S for, which is 5'-GTA AGG GAT GAC GCA CAA TC-3' (SEQ ID NO:8) and RBver-SOErev, which is 5'-GCC AGT CTT CTC CTA TTC CCT TCT CAC ACC GCT TGA TCA-3' (SEQ ID NO:9), and Platinum.RTM. PCR SuperMix High Fidelity (Invitrogen). The other 397 bp intermediate fragment was amplified from S. bulbocastanum RB cDNA in pBI121 using the primers RB-SOEfor, which is 5'-TAA TTA CTC AAT GTC CAA TAG TGA TCA AGC GGT GTG AGA AGG-3' (SEQ ID NO:10) and nosrev, which is 5'-CGT CAT GCA TTA CAT GTT AA-3' (SEQ ID NO:11).

SOE was performed by mixing the PCR products of the two intermediate fragments at a ratio of 1:10 (RB.sup.ver:RB.sup.blb), followed by PCR using primers 35Sfor (SEQ ID NO:8) and nosrev (SEQ ID NO:11). The PCR conditions were: 1 min at 94.degree. C. followed by 40 cycles of 15 sec at 94.degree. C., 30 sec at 52.degree. C., 5 min at 68.degree. C., and 15 min at 68.degree. C. for both intermediate amplification and overlap extension. The PCR product of the complete S. verrucosum RB-like SOE fragment was cloned into a pGEM.RTM.--T Easy Vector and digested with BamHI and XmnI for cloning into pBI121.

Sequence and Clustering Analysis

Double-strand sequencing of DNA was carried out at the University of Wisconsin-Madison Biotechnology Center sequencing facility. Sequence analyses were performed as follows: ambiguous calls were checked against chromatograms using the program ContigExpress (Invitrogen); similarity searches were implemented locally on a Mac OSX workstation using BLAST; open reading frames of the eight RB.sup.ver orthologs were translated into amino acid sequences using the program Vector NTI Explorer (Invitrogen); multiple sequence alignments of the eight RB.sup.ver orthologous proteins with other RB proteins were conducted using the program CLUSTAL-X (Thompson et al., 1997, Nucl. Acids Res. 2524: 4876-4882); PAUP v4.0b10 (Sinauer Associates, Sunderland, Mass.) was used to reconstruct a phylogenetic tree using the neighbor-joining method with 1,000 bootstrap replications; alternative topology was viewed with the program TreeView PPC 1.6.6, obtained from the University of Glasgow, UK.

Sequences of the eight isolated RB orthologs from S. verrucosum have been deposited in the GenBank under the following accession numbers: EF202326 (PI 116173); EF202327 (PI 275256); EF202328 (PI 275258); EF202329 (PI 275260); EF202330 (PI 310966); EF202331 (PI 365404); EF202332 (PI 558485); and EF202333 (PI 570643).

Diversifying Selection Analysis

The rate of nonsynonymous nucleotide substitutions per nonsynonymous site (d.sub.N) and the rate of synonymous nucleotide substitutions per synonymous site (d.sub.S) across all the amino acid sites in pairwise comparisons between nucleotide sequences were estimated using the approximate method of Nei and Gojobori, 1986, Mol. Biol. Evol. 35: 418-426, which was implemented in the YN00 program of the PAML software package (Yang, 1997, Comput. Appl. Biosci. 13: 555-556). In addition, maximum likelihood models of codon substitution were used, which allowed for heterogeneous selection pressures among sites along the protein to identify which amino acids were affected by diversifying selection. Detailed analysis was conducted as described by Liu et al., 2005, Mol. Biol. Evol. 223: 659-672.

Complementation Analysis

Transformation of potato plants with the isolated RB polynucleotide or its fragments was performed. Potato (cv. Katahdin) transformation with a polynucleotide fragment corresponding to the RB gene (RB-like SOE fragment) in the binary vector pBI121 was performed by the Biotechnology Center, University of Wisconsin-Madison. This polynucleotide fragment was mobilized into Agrobacterium tumefaciens LBA4404 for plant transformation. Internodes were taken from three- to four-week-old in vitro grown potato plants cv. Katahdin maintained on PROP medium (Haberlach et al., 1985, Plant Sci. Lett. 39: 67-74). Explants are placed in a suspension of Agrobacterium (4-6.times.10.sup.8 cells/ml) for 30 min, blotted and transferred to ZIG medium (Clearly, 1997, Am. Pot. Journal 74: 125-129) for a 4 day cocultivation. Internodes were then moved to ZIG medium containing 50 mg/L kanamycin to select for transformants and 250 ml/L cefataxine to suppress growth of Agrobacterium. Putative transgenic plantlets were removed from explant pieces 10 to 16 weeks later and rooted on PROP medium.

In one example, Agrobacterium-mediated potato (Solanum tuberosum cv. Katahdin) transformation of the RB.sup.ver gene (from accession PI 275260) in pBI121 was performed by the Plant Biotechnology Center at the University of Wisconsin-Madison. To confirm Kanamycin-resistant transgenic plants, PCR amplification with the transgene-specific primers was performed, using: KanFor1, which is 5'-CGC TTG GGT GGA GAG GCT ATT C-3' (SEQ ID NO:12) and KanRev1, which is 5'-AGG AAG CGG TCA GCC CAT TC-3' (SEQ ID NO:13). Six-week old plants with confirmed insertions of RB.sup.ver were screened and scored for late blight resistance under greenhouse conditions.

Screening for Late Blight Disease Resistance

Whole-plant disease resistance assays were initiated on five different days. Eight-week-old seedlings were placed in a misting chamber (100% humidity, 18.degree. C., 14 hours of light) and were sprayed to run-off with a fine mist of Phytophthora infestans sporangial suspension prepared from US-8, Type A2, Cornell standard ME 93-A2 (WEF#US930287) cultures maintained on rye A medium in a greenhouse facility. The suspension contained approximately 75,000 sporangia/ml and was pre-chilled for 4 h at 10.degree. C. before use. Relative humidity in the greenhouse was maintained at or above 90%. The temperature was maintained at 23.degree. C. during daylight hours (15 h) and dropped to 15.degree. C. at night (9 h).

Foliage blight scores were recorded 69, 92, 116, and 163 hours after inoculation. A blight scale, with 0 indicating a dead plant and 9 no visible infection, was used to visually rate disease severity. All the plants were tested in three repetitions. The ratings and the ranges of percentage infections associated with the rating value are as follows: 9, no visible infection; 8, less than 10% infection; 7, 11-25% infection; 6, 26-40% infection; 5, 41 to 60% infection; 4, 61-70% infection; 3, 71-80% infection; 2, 81-90% infection; 1, greater than 90% infection; 0, all dead (scale according to Colton et al., 2006, Crop Sci. 462: 589-594).

Plants with scores of 8 or above were scored as resistant to late blight and plants with scores of 6.9 or below were scored as susceptible to late blight. Plants with scores between 6.9 and 8 were scored as intermediate resistant.

S. verrucosum Accessions Vary in their Resistance to P. infestans

Late blight resistance levels of eight S. verrucosum accessions were examined using greenhouse inoculations of whole plants. Whole plant inoculations of the eight S. verrucosum accessions were carried out in an environmentally controlled greenhouse, which maintained the relative humidity at or above 90%. Each accession was spray-inoculated with a suspension containing 75,000 sporangia/ml of P. infestans and repeated on five separate dates.

In Table 1, six-week old seedlings were placed in a misting chamber (approximately 100% humidity, 18.degree. C.) and spray inoculated with sporangia from the US 940480 strain of P. infestans. Plants were scored 10 days after inoculation. The late blight resistance score was calculated based on observation of diseased leaf tissue: 0=100% diseased tissue, 8=<10% diseased tissue.

TABLE-US-00001 TABLE 1 Testing of S. verrucosum accessions for resistance to late blight Accession Late blight score PI 161173 6.6 .+-. 1.1 PI 275256 7.0 .+-. 0.7 PI 275258 6.8 .+-. 0.8 PI 275260 7.4 .+-. 0.5 PI 310966 6.2 .+-. 1.1 PI 365404 6.6 .+-. 0.5 PI 558485 6.6 .+-. 1.1 PI 570643 3.2 .+-. 1.6

Most accessions of S. verrucosum displayed high levels of resistance (Table 1). Accession PI 275260 consistently exhibited the strongest resistance to P. infestans with an average resistance score of 7.4.+-.0.5 (0=100% infection, 8=<10% infection). Only PI 570643 exhibited moderate susceptibility to late blight, with a resistance score averaging 3.2.+-.1.6. This accession consistently displayed spreading lesions with water-soaked areas on its lower and upper leaves. Any disease progression on other S. verrucosum accessions was limited to the lower leaves, with little chlorosis and leaf senescence observed.

S. verrucosum Accessions Contain Transcribed RB Orthologous Genes

With primers specific for the S. bulbocastanum RB gene, PCR was performed using genomic DNA from all eight tested S. verrucosum accessions. Unique products, ranging between 3902 and 3916 nt, were amplified and cloned from each accession. Sequencing analysis revealed the presence of only one PCR product from each accession. These products were highly similar to the corresponding RB.sup.blb sequence, suggesting the presence of an RB-like gene in each of these accessions. Sequence analysis also revealed that the amplified products contained 94 nt of the 5' transcript leader region as well as the AUG start codon. However, no 3' primer suitable for amplification of the entire open reading frame was identified. Therefore, each PCR product lacked 50 nt at the 3' end of the coding region. RB orthologs from S. verrucosum accessions PI 116173, PI 275256, PI 275258, PI 310966, and PI 558485 contained a 7-bp frame-shift deletion located 1011 nt downstream of the AUG start codon. Accession PI 365404 contained a 1-bp frame-shift deletion 868 nt downstream of the AUG. Each of these frame-shift mutations results in predicted protein sequences that are truncated with respect to RB.sup.blb. Based on sequence similarity to the RB.sup.blb gene, both accessions PI 275260 and PI 570643 encode potentially full-length CC-NBARC-LRR proteins of 960 amino acids. Complementation analysis demonstrated that the RB ortholog from S. verrucosum PI 275260 is a functional RB gene that confers late blight resistance to P. infestans.

FIG. 1 illustrates the RB orthologous protein sequence from S. verrucosum PI 275260. The three predicted kinase motifs of the NBS domain (kinase 1a/P-loop; kinase 2a; and kinase 3a) are shown above the sequence. Amino acid residues under diversifying selection are shaded in grey.

The bottom part of FIG. 1 illustrates the LRR domains of the predicted RB protein sequence from Solanum verrucosum (RB.sup.ver) ortholog PI 275260. The residues involved in the extra LRR region from S. verrucosum are underlined in LRR 16 and LRR 17. The LRR regions were aligned based on the consensus sequence LXXLXXLXXLXLXXN/CXXLXXLXX (SEQ ID NO:14), where X represents any amino acid.

Nucleotide sequences of the RB.sup.ver orthologs are up to 83.4% identical to RB.sup.blb and have conserved intron-exon structures. The predicted proteins from S. verrucosum contain several insertions or deletions (indels) and share between 82% and 82.6% amino acid identity with the RB.sup.blb protein sequence (Table 2). In Table 2, nucleotide identity percentages are shown above the diagonal line. Amino acid identity percentages are shown below the diagonal line. Only the exon sequences were used.

The predicted protein from P. infestans resistant accession PI 272560 is 82.4% identical to RB.sup.blb. Interestingly, as shown in FIG. 2, the comparison of the leucine rich repeat regions between RB.sup.blb and RB.sup.ver orthologs identified an insertion of a 21 amino acid complete LRR, but no frame-shift. FIG. 2 illustrates multiple sequence alignment of the LRR regions of the eight RB.sup.ver orthologs from S. verrucosum and RB.sup.blb. Single-letter amino acid codes were used. The sequence alignment shown in FIG. 2B represents continuation of the sequence alignment shown in FIG. 2A.

TABLE-US-00002 TABLE 2 Pairwise comparison of nucleotide and amino acid identities among RB.sup.ver and RB.sup.blb genes PI PI PI PI PI PI PI PI RB.sup.blb 161173 275256 275258 275260 310966 365404 558485 570643 RB.sup.blb 88.9 88.9 88.9 88.8 88.7 88.8 88.9 88.8 PI 161173 82.2 99.7 99.9 98.3 99.7 98.3 99.5 98.3 PI 275256 82.2 99.4 99.6 98.2 99.4 98.2 99.3 98.2 PI 275258 82.1 99.4 98.9 98.2 99.6 98.2 99.3 98.2 PI 275260 82.4 97.3 97.0 97.1 98.1 99.8 98.6 99.7 PI 310966 82.0 99.4 98.9 99.2 97.1 98.0 99.2 98.0 PI 365404 82.3 97.2 96.9 97.0 99.7 97.0 98.5 99.7 PI 558485 82.6 99.1 98.8 98.9 97.8 98.9 97.7 98.5 PI 570643 82.4 97.3 97.0 97.1 99.6 97.1 99.5 97.8

To examine whether the RB.sup.ver genes are transcribed, gene-specific RT-PCR was performed on the first-strand cDNA products synthesized from total RNA extracted from the eight S. verrucosum accessions. As shown in FIG. 3, all the eight examined RB.sup.ver genes were transcribed in the absence of pathogen challenge. Specifically, FIG. 3 is an image showing reverse transcription PCR of the RB.sup.ver orthologs using a pair of gene-specific primers. Lane 1: DNA ladder. Lane 2: a genomic DNA copy (gDNA) of the RB.sup.ver gene from PI 275260, including the 928 nt intron, was used as a template. Lanes 3-10: total RNA from the indicated accessions was used as a template for cDNA production and subsequent PCR reactions (lane 3, PI 161173; lane 4, PI 275256; lane 5, PI 275258; lane 6, PI 275260; lane 7, PI 310966; lane 8, PI 365404; lane 9, PI 558485; lane 10, PI 570643).

Phylogenetic Analysis of RB Orthologs

To investigate the protein sequence relationships among the eight RB.sup.ver orthologs, RB.sup.blb, Rpi-blb2, potato late blight resistance protein R1 from S. demissum, and tomato 12 resistance protein, cluster analysis using the neighbor-joining method was performed. The results of this analysis are shown in FIG. 4, which is a dendrogram illustrating clustering analysis of open reading frames of the eight RB.sup.ver orthologs and RB.sup.blb. The phylogenetic tree was constructed using the neighbor joining distance matrix method, based on the conserved overlapping portions of the RB.sup.blb and RB.sup.ver orthologs. Bootstrap values from 1,000 replications >90 are shown at the nodes. The length of the branches reflects weighted amino acid substitutions. RPS2 from Arabidopsis thaliana was included as an outgroup.

Since some predicted RB.sup.ver orthologous proteins contain frame shifts due to deletions, these deletions were replaced with gaps in those protein sequences for further analysis. A total of 1,000 bootstrap replications were conducted to determine the statistical significance of the obtained branches. Two main branches were observed. RB.sup.blb and tomato 12 clustered with all eight S. verrucosum orthologs. The R1 protein was most closely related to Rpi-blb2. Interestingly, RB.sup.ver orthologs from resistant accessions did not necessarily cluster more closely to RB than proteins from susceptible accessions.

The isolated RB.sup.ver gene encodes a RB.sup.ver protein that contains 21 LRRs, one more leucine-rich repeat than the RB.sup.blb protein. Not wanting to be bound by the following theory, the variation of LRRs may play a role in determining recognition specificity of the RB protein. It has been demonstrated that expansion and contraction of LRRs are responsible for loss of function or recognition specificities of plant disease resistance genes. In flax, inactivation of the rust resistance gene M was associated with the loss of a single repeated unit within the LRR coding region (Anderson et al., 1997, Plant Cell 9: 641-651). Sequence analysis of mutant RPP5 alleles identified four duplicated LRRs in comparison to the wild-type RPP5 gene (Parker et al., 1997, Plant Cell 9: 879-894). Domain swapping and gene shuffling of tomato Cf-4 and Cf-9 protein also demonstrated that variation in LRR copy number plays a major role in determining recognition specificity in these proteins (Wulff et al., 2001, Plant Cell 13: 255-272). It is possible that a similar mechanism exists with the recognition specificity relative to Phytophthora infections.

Not wanting to be bound by the following theory, based on the protein sequence (SEQ ID NO:2), the RB.sup.ver protein may belong to the NBS-LRR class of RB proteins. Its putative NBS domain consists of three motifs: kinase 1a or P-loop, kinase 2, and kinase 3a (FIG. 1). Downstream of the kinase motifs is a domain conserved among resistance genes, which contains QLPL, CFAY, and MHD motifs. The RB protein contains one putative five-heptad leucine zipper motif near the N terminus. Another region containing four heptad repeats can be observed within the LRR domain. As indicated above, the LRR domain consists of 21 leucine-rich repeats.

The RB.sup.Ver Proteins are Under Diversifying Selection

The gene RB has a similar evolutionary pattern to Type II resistance genes (Song et al., 2003, Proc. Natl. Acad. Sci. USA 10016: 9128-9133). Type II resistance genes are predicted to evolve slowly and show striking allelic/orthologous relationships in different genotypes or closely related species. Therefore, little diversifying selection would be expected when comparing the RB.sup.blb and RB.sup.ver sequences. To test this hypothesis, the average ratios of the numbers of nonsynonymous nucleotide substitutions per nonsynonymous site (d.sub.N) and synonymous nucleotide substitutions per synonymous site (d.sub.S) among the eight RB.sup.ver orthologous sequences and RB.sup.blb were calculated, using the approximate method of Nei and Gojobori in PAML (Nei and Gojobori, 1986, Mol. Biol. Evol. 35: 418-426).

Using this method, no diversifying selection was detected. In most proteins, a high proportion of amino acid sites is expected to be highly conserved as a result of functional constraints, and neutral and purifying selection are thought to be major forces in molecular evolution. Under these circumstances, the approximate method should not be sensitive enough to detect diversifying selection because it averages the .omega. ratios over all sites of the protein. Subsequently, a more sensitive Maximum Likelihood (ML) method was applied (Nielsen and Yang, 1998, Genetics 1483: 929-936; Fu et al., 2000, Yi Chuan Xue Bao 279: 787-791; Yang and Bielawski, 2000, Trends Ecol. Evol. 15: 496-503). One pair of ML models of codon substitution, M3/M0, was used. The discrete model M3 suggested that 22% of the amino acid sites are under diversifying selection (.omega..sub.1=1.2) and 3% of the amino acid sites are under strong diversifying selection (.omega..sub.2=8.5). A likelihood ratio test (LRT) indicated that the discrete model M3 fit the data significantly better than the neutral model M0, which did not allow for the presence of diversifying selection sites with .omega.>1 (P<0.001). Twelve amino acid sites (those with posterior probability values over 0.9) were implicated as being under significant diversifying selection under the discrete model M3 using the empirical Bayes theorem (FIG. 5) (Nielsen and Yang, 1998, Genetics 1483: 929-936; Fu et al., 2000, Yi Chuan Xue Bao 279: 787-791; Yang and Bielawski, 2000, Trends Ecol. Evol. 15: 496-503).

FIG. 5 illustrates posterior probabilities for site classes (.omega.>1) estimated under the discrete model M3 in PAML along the RB.sup.ver orthologous protein sequence. The X-axis denotes the position in the amino acid alignment. An amino acid site with a posterior probability >0.9 (indicated with a horizontal line) is considered to be under significant diversifying selection. As shown in FIG. 5, twelve such amino acid sites were identified. As is also shown in FIG. 1, these residues are: lys58, glu82, arg176, lue181, gln251, asp465, val498, phe509, his580, cys626, gln636, thr949. Eight of the twelve amino acid sites are located outside the LRRs while four lie within the LRR repeats. Not wanting to be bound by the following theory, the sites under diversifying selection identify amino acids that may have a role in pathogen recognition. Thus, using the sequence data in FIG. 1 and the information on amino acid sites that are under significant diversifying selection, shown in FIG. 5, it may be possible to identify and/or generate additional orthologs or variants useful for practicing the present invention.

Complementation Analysis of an RB Ortholog from S. verrucosum PI 275260

In order to test whether the RB.sup.ver ortholog from resistant accession PI 275260 could complement the P. infestans susceptible phenotype in cultivated potato, S. tuberosum cv. Katahdin was transformed with a full-length open reading frame of this gene under control of the 35S cauliflower mosaic virus promoter and the nopaline synthase terminator (nos). Forty-nine transgenic RB.sup.ver Katahdin plants were screened for resistance to P. infestans isolate US 940480. PCR using transgene-specific primers confirmed the presence of the gene in 36 out of these 49 transgenic Katahdin plants. Surprisingly, only four out of the 36 plants, each from independently isolated explants, consistently displayed increased resistance to P. infestans (Table 3). Six-week-old seedlings were placed in a misting chamber (100% humidity, 18.degree. C.) and spray inoculated with sporangia from the US 940480 strain of P. infestans. Plants were scored 10 days after inoculation. The late blight resistance score shown in Table 3 was calculated based on observation of diseased leaf tissue: 0=100% diseased tissue, 8=<10% diseased tissue. For complementation analysis of a putative RB.sup.ver orthologous gene for late blight resistance, disease symptoms were recorded 10 days after inoculation. Susceptible S. tuberosum cv. Katahdin and resistant RB.sup.blb-transgenic plants SP951 were provided by Sandra Austin-Phillips, University of Wisconsin-Madison Biotechnology Center, and were used as controls (Halterman et al., 2008, Plant Dis. 92: 339-343).

The relatively low number of functional transformants suggests that proper expression of RB might be critical for plant viability or expression of the resistance phenotype. Among the four plants exhibiting the resistance phenotype, only some chlorosis was observed on the lower leaves, confirming the functionality of the RB ortholog from S. verrucosum PI 275260 in potato. Similar to the RB.sup.blb transgenics, these RB.sup.ver transgenic lines exhibit rate-limiting resistance to P. infestans suggesting the presence of other major genes required for complete resistance.

TABLE-US-00003 TABLE 3 Testing of RB.sup.ver transgenics for resistance to late blight Plants Late blight score Katahdin 4 .+-. 1.0 SP951 8 .+-. 0.0 SP2808 6 .+-. 2.7 SP2824 6.5 .+-. 0.5 SP2829 4.7 .+-. 2.1 SP2906 7 .+-. 1.0

It is to be understood that this invention is not limited to the particular devices, methodology, protocols, subjects, or reagents described, and as such may vary. It is also to be understood that the terminology used herein is for the purpose of describing particular embodiments only, and is not intended to limit the scope of the present invention, which is limited only by the claims. Other suitable modifications and adaptations of a variety of conditions and parameters normally encountered in plant physiology, plant molecular biology, and plant pathology, and obvious to those skilled in the art, are within the scope of this invention. All publications, patents, and patent applications cited herein are incorporated by reference in their entirety for all purposes.

SEQUENCE LISTINGS

1

4513903DNASolanum verrucosum 1cttcccattt cattccaact agcccatctt ggcttcaaaa ttacacattc attcatagtc 60acagatctaa tattcttaat agtgatttcc acatatggct gaagctttca ttcaagttct 120gctagacaat ctcacttctg tcctcaaagg agaacttgta ttgcttttcg gttttcaaga 180tgagttccaa aggctttcaa gcatcttctc tacaatccaa gctgtccttg aagatgctca 240ggagaagcaa ctcaacgaca agccactaga aaattggttg caaaaactca atgctgctac 300atatgaagtc gatgacatct tggatgaata taaaactgag gccacaagat tcttgcagtc 360tgaatatggc cgttatcatc caaaggcaat ccctttccgt cacaaggttg ggaaaaggat 420ggaccaagtg atgaaaaaac tgaatgcaat tgctgaggaa agaaagaatt tccatttgca 480agaaaagatt atagagagac aagctgctac acgggaaaca ggtactcatc ttaaattagt 540agtattacaa cttagtttat attcattcat ttgttttggg caatgatcaa attatgtaaa 600ggtcaaatat actcatgtac tattggaaat agtttaaata tacctctagt tatactttca 660gtgcaaacat actcctccca tatagaagac tacatccgtt ttgcttttct taacgaagca 720gctcagagaa aagaggtttt cttctgttct gtttctctat gggctgcatt ggggtcttaa 780tccaataaga aacaataaac ataacaggca tatttaacaa attaatatta cgttctcgat 840gacggtggtc tttctagaca tgaactgagt gtaaattttg gtaaattttg tctcaaggaa 900gaaaaagaaa tgattaggct ggatttcttt cagagtggaa tataggggga taaagttgga 960gcatagagtt ccatcgttta tttcttacat aaaagtaaca agttcaacaa aatgatatca 1020aggtacttta atggaaaatt atcagacacg tctaaactac aaaaatggaa tagaaactta 1080aatcatcctc taacaaagct accaaattta aatcatgata cagagaagca accaaaaaca 1140ttatgggtga attgtttgat ttgatgcttg tcacatgtct tcccgtcaag attaaaggaa 1200aaattgcgcc gaagtataaa tggtgcagta tatttggact aatagtataa cgacaagtat 1260atttgatcat tttatgtatc aaattcatgt ggtttttggg gagaagggaa gtttcaaagt 1320tttcaacctg ctcctcatct catccatatc tctttattgt gcaaaaccct tttctattta 1380actattttct gccgactcct aatgagcttg aatgtaacaa tattctcatc tggacattgc 1440ttgcaccagg ttctgtgtta actgaaccac aagtttatgg aagggacaaa gaaaatgatg 1500agatagtgaa aatcctaata aacaatgcta gtgatgccca aaaactcaga gtcctcccaa 1560tacttggtat ggggggacta ggaaagacaa ctctttccca aatggtcttc aatgatcaga 1620gagtaactga acatttctat cccaaactgt ggatttgtgt ctccaatgat tttgatgaga 1680agaggttgat aaaggcaata gtagaatcta ttgaagggaa gtcactcagt gacatggact 1740tggctccact tcaaaagaag cttcaagagt tgcagaatgg aaaaagatac ttgcttgtct 1800tagatgatgt ttggaatgaa gatcaacaga agtgggctaa tttaagagca gtgttgaagg 1860ttggagcaag tggttcattt gttctaacta ctactcgtct tgaaaaggtt ggatcaatta 1920tgggaacatt gcaaccatat gaattgtcaa atctgtctcc agaggattgt tggtttttgt 1980tcatacagcg tgcatttgga caccaagaag aaataaatcc aaaccttgtg gatatcggaa 2040aggagattat gaaaaaaagt ggtggtgtgc ctctagcagc caagactctt ggaggtattt 2100tgcgcttcaa gagagaagaa agagaatggg aacatgtgag agacagtccg atttggaatt 2160tgcctcaaga tgaaagttct attctgcctg ccctgaggct tagttaccat caccttccac 2220ttgatttgag acaatgcttt gtgtattgtg cggtattccc gaaggacacc aaaatggcaa 2280aggaaaatct aatcgctttc tggatggcac acggttttct tttatcgaaa ggaaatttgg 2340agctagagga tgtaggtaat gaagtatgga atgaattata cttgaggtct ttcttccaag 2400agattgaagt taaagatggt aaaacttatt tcaagatgca tgatctcatc catgatttgg 2460ctacatctct gttttcagca aacacatcaa gcagcaacat tcgtgaaata tatgttaatt 2520atgatggata tatgatgtcg attggtttcg ctgaagtggt gtcttcttac tctccttcac 2580tcttgcaaaa gtttgtctca ttaagagtgc ttaatctaag aaactcggac ctaaatcaat 2640taccatcctc cattggagat ctagtacatt taagatacct ggacttgtct gacaatatta 2700gaattcgtag tcttccaaag agattatgca agcttcaaaa tctgcagact cttgatctac 2760ataattgcta ctctctttct tgtttgccaa aacaaacaag taaacttggt agtctccgaa 2820atcttttact tgatggctgt tcattgacgt caacgccacc aaggatagga ttgttgacat 2880gccttaagtc tctaagttgc tttgttattg gcaagagaaa aggttatcaa cttggtgaac 2940taaaaaacct aaatctctat ggctcaattt caatcacaaa acttgagaga gtgaagaaag 3000gaagggatgc aaaagaagct aatatatctg ttaaagcaaa tctgcactct ttaagcctga 3060gttgggattt tgatggaaca catagatatg aatcagaagt tcttgaagcc ctcaaaccac 3120actccaatct gaaatattta gaaatcattg gcttcagagg aatccgtctc ccagactgga 3180tgaatcaatc agttttgaaa aatgttgtct ctattacaat tagaggttgt gaaaactgct 3240cgtgcttacc accctttggt gagctgccta gtctagaaag tctagagtta cacacggggt 3300ctgcggaggt ggagtatgtt gaagagaatg ctcatcctgg aaggtttcca tccttgagga 3360aacttgttat ttgcgacttt ggtaatctga aaggattgct gaaaaaggaa ggagaagagc 3420aatttcctgt gcttgaagag atgacaattc acgggtgccc tatgtttgtt attccgaccc 3480tttcttctgt caagacattg aaagttgatg tgacagatgc aacagttttg aggtccatat 3540ctaatcttag ggctcttact tcgctcgaca ttagcagtaa ctatgaagct acttcactcc 3600cagaagagat gttcaaaaac cttgcagatc tcaaagactt gactatctct gacttcaaga 3660atctcaaaga gctgcctacc tgcctggcta gtctcaatgc tttgaatagt ctacaaattg 3720aatattgtga cgcactagag agtctcccag aggaaggggt taaaagttta acttcactca 3780ccgagttgtc tgtcagtaat tgtatgacgc taaaatgttt accggaggga ttgcagcacc 3840taacagccct aacaacttta ataattactc aatgtccaat agtgatcaag cggtgtgaga 3900agg 39032960PRTSolanum verrucosum 2Met Ala Glu Ala Phe Ile Gln Val Leu Leu Asp Asn Leu Thr Ser Val1 5 10 15Leu Lys Gly Glu Leu Val Leu Leu Phe Gly Phe Gln Asp Glu Phe Gln 20 25 30Arg Leu Ser Ser Ile Phe Ser Thr Ile Gln Ala Val Leu Glu Asp Ala 35 40 45Gln Glu Lys Gln Leu Asn Asp Lys Pro Leu Glu Asn Trp Leu Gln Lys 50 55 60Leu Asn Ala Ala Thr Tyr Glu Val Asp Asp Ile Leu Asp Glu Tyr Lys65 70 75 80Thr Glu Ala Thr Arg Phe Leu Gln Ser Glu Tyr Gly Arg Tyr His Pro 85 90 95Lys Ala Ile Pro Phe Arg His Lys Val Gly Lys Arg Met Asp Gln Val 100 105 110Met Lys Lys Leu Asn Ala Ile Ala Glu Glu Arg Lys Asn Phe His Leu 115 120 125Gln Glu Lys Ile Ile Glu Arg Gln Ala Ala Thr Arg Glu Thr Gly Ser 130 135 140Val Leu Thr Glu Pro Gln Val Tyr Gly Arg Asp Lys Glu Asn Asp Glu145 150 155 160Ile Val Lys Ile Leu Ile Asn Asn Ala Ser Asp Ala Gln Lys Leu Arg 165 170 175Val Leu Pro Ile Leu Gly Met Gly Gly Leu Gly Lys Thr Thr Leu Ser 180 185 190Gln Met Val Phe Asn Asp Gln Arg Val Thr Glu His Phe Tyr Pro Lys 195 200 205Leu Trp Ile Cys Val Ser Asn Asp Phe Asp Glu Lys Arg Leu Ile Lys 210 215 220Ala Ile Val Glu Ser Ile Glu Gly Lys Ser Leu Ser Asp Met Asp Leu225 230 235 240Ala Pro Leu Gln Lys Lys Leu Gln Glu Leu Gln Asn Gly Lys Arg Tyr 245 250 255Leu Leu Val Leu Asp Asp Val Trp Asn Glu Asp Gln Gln Lys Trp Ala 260 265 270Asn Leu Arg Ala Val Leu Lys Val Gly Ala Ser Gly Ser Phe Val Leu 275 280 285Thr Thr Thr Arg Leu Glu Lys Val Gly Ser Ile Met Gly Thr Leu Gln 290 295 300Pro Tyr Glu Leu Ser Asn Leu Ser Pro Glu Asp Cys Trp Phe Leu Phe305 310 315 320Ile Gln Arg Ala Phe Gly His Gln Glu Glu Ile Asn Pro Asn Leu Val 325 330 335Asp Ile Gly Lys Glu Ile Met Lys Lys Ser Gly Gly Val Pro Leu Ala 340 345 350Ala Lys Thr Leu Gly Gly Ile Leu Arg Phe Lys Arg Glu Glu Arg Glu 355 360 365Trp Glu His Val Arg Asp Ser Pro Ile Trp Asn Leu Pro Gln Asp Glu 370 375 380Ser Ser Ile Leu Pro Ala Leu Arg Leu Ser Tyr His His Leu Pro Leu385 390 395 400Asp Leu Arg Gln Cys Phe Val Tyr Cys Ala Val Phe Pro Lys Asp Thr 405 410 415Lys Met Ala Lys Glu Asn Leu Ile Ala Phe Trp Met Ala His Gly Phe 420 425 430Leu Leu Ser Lys Gly Asn Leu Glu Leu Glu Asp Val Gly Asn Glu Val 435 440 445Trp Asn Glu Leu Tyr Leu Arg Ser Phe Phe Gln Glu Ile Glu Val Lys 450 455 460Asp Gly Lys Thr Tyr Phe Lys Met His Asp Leu Ile His Asp Leu Ala465 470 475 480Thr Ser Leu Phe Ser Ala Asn Thr Ser Ser Ser Asn Ile Arg Glu Ile 485 490 495Tyr Val Asn Tyr Asp Gly Tyr Met Met Ser Ile Gly Phe Ala Glu Val 500 505 510Val Ser Ser Tyr Ser Pro Ser Leu Leu Gln Lys Phe Val Ser Leu Arg 515 520 525Val Leu Asn Leu Arg Asn Ser Asp Leu Asn Gln Leu Pro Ser Ser Ile 530 535 540Gly Asp Leu Val His Leu Arg Tyr Leu Asp Leu Ser Asp Asn Ile Arg545 550 555 560Ile Arg Ser Leu Pro Lys Arg Leu Cys Lys Leu Gln Asn Leu Gln Thr 565 570 575Leu Asp Leu His Asn Cys Tyr Ser Leu Ser Cys Leu Pro Lys Gln Thr 580 585 590Ser Lys Leu Gly Ser Leu Arg Asn Leu Leu Leu Asp Gly Cys Ser Leu 595 600 605Thr Ser Thr Pro Pro Arg Ile Gly Leu Leu Thr Cys Leu Lys Ser Leu 610 615 620Ser Cys Phe Val Ile Gly Lys Arg Lys Gly Tyr Gln Leu Gly Glu Leu625 630 635 640Lys Asn Leu Asn Leu Tyr Gly Ser Ile Ser Ile Thr Lys Leu Glu Arg 645 650 655Val Lys Lys Gly Arg Asp Ala Lys Glu Ala Asn Ile Ser Val Lys Ala 660 665 670Asn Leu His Ser Leu Ser Leu Ser Trp Asp Phe Asp Gly Thr His Arg 675 680 685Tyr Glu Ser Glu Val Leu Glu Ala Leu Lys Pro His Ser Asn Leu Lys 690 695 700Tyr Leu Glu Ile Ile Gly Phe Arg Gly Ile Arg Leu Pro Asp Trp Met705 710 715 720Asn Gln Ser Val Leu Lys Asn Val Val Ser Ile Thr Ile Arg Gly Cys 725 730 735Glu Asn Cys Ser Cys Leu Pro Pro Phe Gly Glu Leu Pro Ser Leu Glu 740 745 750Ser Leu Glu Leu His Thr Gly Ser Ala Glu Val Glu Tyr Val Glu Glu 755 760 765Asn Ala His Pro Gly Arg Phe Pro Ser Leu Arg Lys Leu Val Ile Cys 770 775 780Asp Phe Gly Asn Leu Lys Gly Leu Leu Lys Lys Glu Gly Glu Glu Gln785 790 795 800Phe Pro Val Leu Glu Glu Met Thr Ile His Gly Cys Pro Met Phe Val 805 810 815Ile Pro Thr Leu Ser Ser Val Lys Thr Leu Lys Val Asp Val Thr Asp 820 825 830Ala Thr Val Leu Arg Ser Ile Ser Asn Leu Arg Ala Leu Thr Ser Leu 835 840 845Asp Ile Ser Ser Asn Tyr Glu Ala Thr Ser Leu Pro Glu Glu Met Phe 850 855 860Lys Asn Leu Ala Asp Leu Lys Asp Leu Thr Ile Ser Asp Phe Lys Asn865 870 875 880Leu Lys Glu Leu Pro Thr Cys Leu Ala Ser Leu Asn Ala Leu Asn Ser 885 890 895Leu Gln Ile Glu Tyr Cys Asp Ala Leu Glu Ser Leu Pro Glu Glu Gly 900 905 910Val Lys Ser Leu Thr Ser Leu Thr Glu Leu Ser Val Ser Asn Cys Met 915 920 925Thr Leu Lys Cys Leu Pro Glu Gly Leu Gln His Leu Thr Ala Leu Thr 930 935 940Thr Leu Ile Ile Thr Gln Cys Pro Ile Val Ile Lys Arg Cys Glu Lys945 950 955 96032880DNASolanum verrucosum 3atggctgaag ctttcattca agttctgcta gacaatctca cttctgtcct caaaggagaa 60cttgtattgc ttttcggttt tcaagatgag ttccaaaggc tttcaagcat cttctctaca 120atccaagctg tccttgaaga tgctcaggag aagcaactca acgacaagcc actagaaaat 180tggttgcaaa aactcaatgc tgctacatat gaagtcgatg acatcttgga tgaatataaa 240actgaggcca caagattctt gcagtctgaa tatggccgtt atcatccaaa ggcaatccct 300ttccgtcaca aggttgggaa aaggatggac caagtgatga aaaaactgaa tgcaattgct 360gaggaaagaa agaatttcca tttgcaagaa aagattatag agagacaagc tgctacacgg 420gaaacaggtt ctgtgttaac tgaaccacaa gtttatggaa gggacaaaga aaatgatgag 480atagtgaaaa tcctaataaa caatgctagt gatgcccaaa aactcagagt cctcccaata 540cttggtatgg ggggactagg aaagacaact ctttcccaaa tggtcttcaa tgatcagaga 600gtaactgaac atttctatcc caaactgtgg atttgtgtct ccaatgattt tgatgagaag 660aggttgataa aggcaatagt agaatctatt gaagggaagt cactcagtga catggacttg 720gctccacttc aaaagaagct tcaagagttg cagaatggaa aaagatactt gcttgtctta 780gatgatgttt ggaatgaaga tcaacagaag tgggctaatt taagagcagt gttgaaggtt 840ggagcaagtg gttcatttgt tctaactact actcgtcttg aaaaggttgg atcaattatg 900ggaacattgc aaccatatga attgtcaaat ctgtctccag aggattgttg gtttttgttc 960atacagcgtg catttggaca ccaagaagaa ataaatccaa accttgtgga tatcggaaag 1020gagattatga aaaaaagtgg tggtgtgcct ctagcagcca agactcttgg aggtattttg 1080cgcttcaaga gagaagaaag agaatgggaa catgtgagag acagtccgat ttggaatttg 1140cctcaagatg aaagttctat tctgcctgcc ctgaggctta gttaccatca ccttccactt 1200gatttgagac aatgctttgt gtattgtgcg gtattcccga aggacaccaa aatggcaaag 1260gaaaatctaa tcgctttctg gatggcacac ggttttcttt tatcgaaagg aaatttggag 1320ctagaggatg taggtaatga agtatggaat gaattatact tgaggtcttt cttccaagag 1380attgaagtta aagatggtaa aacttatttc aagatgcatg atctcatcca tgatttggct 1440acatctctgt tttcagcaaa cacatcaagc agcaacattc gtgaaatata tgttaattat 1500gatggatata tgatgtcgat tggtttcgct gaagtggtgt cttcttactc tccttcactc 1560ttgcaaaagt ttgtctcatt aagagtgctt aatctaagaa actcggacct aaatcaatta 1620ccatcctcca ttggagatct agtacattta agatacctgg acttgtctga caatattaga 1680attcgtagtc ttccaaagag attatgcaag cttcaaaatc tgcagactct tgatctacat 1740aattgctact ctctttcttg tttgccaaaa caaacaagta aacttggtag tctccgaaat 1800cttttacttg atggctgttc attgacgtca acgccaccaa ggataggatt gttgacatgc 1860cttaagtctc taagttgctt tgttattggc aagagaaaag gttatcaact tggtgaacta 1920aaaaacctaa atctctatgg ctcaatttca atcacaaaac ttgagagagt gaagaaagga 1980agggatgcaa aagaagctaa tatatctgtt aaagcaaatc tgcactcttt aagcctgagt 2040tgggattttg atggaacaca tagatatgaa tcagaagttc ttgaagccct caaaccacac 2100tccaatctga aatatttaga aatcattggc ttcagaggaa tccgtctccc agactggatg 2160aatcaatcag ttttgaaaaa tgttgtctct attacaatta gaggttgtga aaactgctcg 2220tgcttaccac cctttggtga gctgcctagt ctagaaagtc tagagttaca cacggggtct 2280gcggaggtgg agtatgttga agagaatgct catcctggaa ggtttccatc cttgaggaaa 2340cttgttattt gcgactttgg taatctgaaa ggattgctga aaaaggaagg agaagagcaa 2400tttcctgtgc ttgaagagat gacaattcac gggtgcccta tgtttgttat tccgaccctt 2460tcttctgtca agacattgaa agttgatgtg acagatgcaa cagttttgag gtccatatct 2520aatcttaggg ctcttacttc gctcgacatt agcagtaact atgaagctac ttcactccca 2580gaagagatgt tcaaaaacct tgcagatctc aaagacttga ctatctctga cttcaagaat 2640ctcaaagagc tgcctacctg cctggctagt ctcaatgctt tgaatagtct acaaattgaa 2700tattgtgacg cactagagag tctcccagag gaaggggtta aaagtttaac ttcactcacc 2760gagttgtctg tcagtaattg tatgacgcta aaatgtttac cggagggatt gcagcaccta 2820acagccctaa caactttaat aattactcaa tgtccaatag tgatcaagcg gtgtgagaag 2880424DNAArtificialF1 primer 4cttcccattt cattccaact agcc 24522DNAArtificialR14 primer 5ccttctcaca ccgcttgatc ag 22625DNAArtificialF3 primer 6tcaagccgtc cttgaagatg ctcag 25724DNAArtificialR3 primer 7ggcgaaacca atggacatca tatg 24820DNAArtificial35Sfor primer 8gtaagggatg acgcacaatc 20939DNAArtificialRBver-SOErev primer 9gccagtcttc tcctattccc ttctcacacc gcttgatca 391042DNAArtificialRB-SOEfor primer 10taattactca atgtccaata gtgatcaagc ggtgtgagaa gg 421120DNAArtificialnosrev primer 11cgtcatgcat tacatgttaa 201222DNAArtificialKanFor1 primer 12cgcttgggtg gagaggctat tc 221320DNAArtificialKanRev1 primer 13aggaagcggt cagcccattc 201424PRTArtificial SequenceConsensus sequence for alignment of LRR regions 14Leu Xaa Xaa Leu Xaa Xaa Leu Xaa Xaa Leu Xaa Leu Xaa Xaa Asn Cys1 5 10 15Xaa Xaa Leu Xaa Xaa Leu Xaa Xaa 2015520PRTSolanum verrucosum 15Met Ala Glu Ala Phe Ile Gln Val Leu Leu Asp Asn Leu Thr Ser Val1 5 10 15Leu Lys Gly Glu Leu Val Leu Leu Phe Gly Phe Gln Asp Glu Phe Gln 20 25 30Arg Leu Ser Ser Ile Phe Ser Thr Ile Gln Ala Val Leu Glu Asp Ala 35 40 45Gln Glu Lys Gln Leu Asn Asp Lys Pro Leu Glu Asn Trp Leu Gln Lys 50 55 60Leu Asn Ala Ala Thr Tyr Glu Val Asp Asp Ile Leu Asp Glu Tyr Lys65 70 75 80Thr Glu Ala Thr Arg Phe Leu Gln Ser Glu Tyr Gly Arg Tyr His Pro 85 90 95Lys Ala Ile Pro Phe Arg His Lys Val Gly Lys Arg Met Asp Gln Val 100 105 110Met Lys Lys Leu Asn Ala Ile Ala Glu Glu Arg Lys Asn Phe His Leu 115 120 125Gln Glu Lys Ile Ile Glu Arg Gln Ala Ala Thr Arg Glu Thr Gly Ser 130 135 140Val Leu Thr Glu Pro Gln Val Tyr Gly Arg Asp Lys Glu Asn Asp Glu145 150 155 160Ile Val Lys Ile Leu Ile Asn Asn Ala Ser Asp Ala Gln Lys Leu Arg 165 170 175Val Leu Pro Ile Leu Gly Met Gly Gly Leu Gly Lys Thr Thr Leu Ser 180 185 190Gln

Met Val Phe Asn Asp Gln Arg Val Thr Glu His Phe Tyr Pro Lys 195 200 205Leu Trp Ile Cys Val Ser Asn Asp Phe Asp Glu Lys Arg Leu Ile Lys 210 215 220Ala Ile Val Glu Ser Ile Glu Gly Lys Ser Leu Ser Asp Met Asp Leu225 230 235 240Ala Pro Leu Gln Lys Lys Leu Gln Glu Leu Gln Asn Gly Lys Arg Tyr 245 250 255Leu Leu Val Leu Asp Asp Val Trp Asn Glu Asp Gln Gln Lys Trp Ala 260 265 270Asn Leu Arg Ala Val Leu Lys Val Gly Ala Ser Gly Ser Phe Val Leu 275 280 285Thr Thr Thr Arg Leu Glu Lys Val Gly Ser Ile Met Gly Thr Leu Gln 290 295 300Pro Tyr Glu Leu Ser Asn Leu Ser Pro Glu Asp Cys Trp Phe Leu Phe305 310 315 320Ile Gln Arg Ala Phe Gly His Gln Glu Glu Ile Asn Pro Asn Leu Val 325 330 335Asp Ile Gly Lys Glu Ile Met Lys Lys Ser Gly Gly Val Pro Leu Ala 340 345 350Ala Lys Thr Leu Gly Gly Ile Leu Arg Phe Lys Arg Glu Glu Arg Glu 355 360 365Trp Glu His Val Arg Asp Ser Pro Ile Trp Asn Leu Pro Gln Asp Glu 370 375 380Ser Ser Ile Leu Pro Ala Leu Arg Leu Ser Tyr His His Leu Pro Leu385 390 395 400Asp Leu Arg Gln Cys Phe Val Tyr Cys Ala Val Phe Pro Lys Asp Thr 405 410 415Lys Met Ala Lys Glu Asn Leu Ile Ala Phe Trp Met Ala His Gly Phe 420 425 430Leu Leu Ser Lys Gly Asn Leu Glu Leu Glu Asp Val Gly Asn Glu Val 435 440 445Trp Asn Glu Leu Tyr Leu Arg Ser Phe Phe Gln Glu Ile Glu Val Lys 450 455 460Asp Gly Lys Thr Tyr Phe Lys Met His Asp Leu Ile His Asp Leu Ala465 470 475 480Thr Ser Leu Phe Ser Ala Asn Thr Ser Ser Ser Asn Ile Arg Glu Ile 485 490 495Tyr Val Asn Tyr Asp Gly Tyr Met Met Ser Ile Gly Phe Ala Glu Val 500 505 510Val Ser Ser Tyr Ser Pro Ser Leu 515 5201623PRTSolanum verrucosum 16Leu Gln Lys Phe Val Ser Leu Arg Val Leu Asn Leu Arg Asn Ser Asp1 5 10 15Leu Asn Gln Leu Pro Ser Ser 201724PRTSolanum verrucosum 17Ile Gly Asp Leu Val His Leu Arg Tyr Leu Asp Leu Ser Asp Asn Ile1 5 10 15Arg Ile Arg Ser Leu Pro Lys Arg 201824PRTSolanum verrucosum 18Leu Cys Lys Leu Gln Asn Leu Gln Thr Leu Asp Leu His Asn Cys Tyr1 5 10 15Ser Leu Ser Cys Leu Pro Lys Gln 201926PRTSolanum verrucosum 19Thr Ser Lys Leu Gly Ser Leu Arg Asn Leu Leu Leu Asp Gly Cys Ser1 5 10 15Leu Thr Ser Thr Pro Pro Arg Ile Gly Leu 20 252016PRTSolanum verrucosum 20Leu Thr Cys Leu Lys Ser Leu Ser Cys Phe Val Ile Gly Lys Arg Lys1 5 10 152114PRTSolanum verrucosum 21Gly Tyr Gln Leu Gly Glu Leu Lys Asn Leu Asn Leu Tyr Gly1 5 102220PRTSolanum verrucosum 22Ser Ile Ser Ile Thr Lys Leu Glu Arg Val Lys Lys Gly Arg Asp Ala1 5 10 15Lys Glu Ala Asn 202323PRTSolanum verrucosum 23Ile Ser Val Lys Ala Asn Leu His Ser Leu Ser Leu Ser Trp Asp Phe1 5 10 15Asp Gly Thr His Arg Tyr Glu 202414PRTSolanum verrucosum 24Ser Glu Val Leu Glu Ala Leu Lys Pro His Ser Asn Leu Lys1 5 102517PRTSolanum verrucosum 25Tyr Leu Glu Ile Ile Gly Phe Arg Gly Ile Arg Leu Pro Asp Trp Met1 5 10 15Asn2623PRTSolanum verrucosum 26Gln Ser Val Leu Lys Asn Val Val Ser Ile Thr Ile Arg Gly Cys Glu1 5 10 15Asn Cys Ser Cys Leu Pro Pro 202715PRTSolanum verrucosum 27Phe Gly Glu Leu Pro Ser Leu Glu Ser Leu Glu Leu His Thr Gly1 5 10 152812PRTSolanum verrucosum 28Ser Ala Glu Val Glu Tyr Val Glu Glu Asn Ala His1 5 102926PRTSolanum verrucosum 29Pro Gly Arg Phe Pro Ser Leu Arg Lys Leu Val Ile Cys Asp Phe Gly1 5 10 15Asn Leu Lys Gly Leu Leu Lys Lys Glu Gly 20 253019PRTSolanum verrucosum 30Glu Glu Gln Phe Pro Val Leu Glu Glu Met Thr Ile His Gly Cys Pro1 5 10 15Met Phe Val3122PRTSolanum verrucosum 31Ile Pro Thr Leu Ser Ser Val Lys Thr Leu Lys Val Asp Val Thr Asp1 5 10 15Ala Thr Val Leu Arg Ser 203225PRTSolanum verrucosum 32Ile Ser Asn Leu Arg Ala Leu Thr Ser Leu Asp Ile Ser Ser Asn Tyr1 5 10 15Glu Ala Thr Ser Leu Pro Glu Glu Met 20 253324PRTSolanum verrucosum 33Phe Lys Asn Leu Ala Asp Leu Lys Asp Leu Thr Ile Ser Asp Phe Lys1 5 10 15Asn Leu Lys Glu Leu Pro Thr Cys 203425PRTSolanum verrucosum 34Leu Ala Ser Leu Asn Ala Leu Asn Ser Leu Gln Ile Glu Tyr Cys Asp1 5 10 15Ala Leu Glu Ser Leu Pro Glu Glu Gly 20 253524PRTSolanum verrucosum 35Val Lys Ser Leu Thr Ser Leu Thr Glu Leu Ser Val Ser Asn Cys Met1 5 10 15Thr Leu Lys Cys Leu Pro Glu Gly 203625PRTSolanum verrucosum 36Leu Gln His Leu Thr Ala Leu Thr Thr Leu Ile Ile Thr Gln Cys Pro1 5 10 15Ile Val Ile Lys Arg Cys Glu Lys Glu 20 2537449PRTSolanum verrucosum 37Leu Glu Lys Phe Ile Ser Leu Arg Val Leu Asn Leu Gly Asp Ser Thr1 5 10 15Phe Asn Lys Leu Pro Ser Ser Ile Gly Asp Leu Val His Leu Arg Tyr 20 25 30Leu Asn Leu Tyr Gly Ser Gly Met Arg Ser Leu Pro Lys Gln Leu Cys 35 40 45Lys Leu Gln Asn Leu Gln Thr Leu Asp Leu Gln Tyr Cys Thr Lys Leu 50 55 60Cys Cys Leu Pro Lys Glu Thr Ser Lys Leu Gly Ser Leu Arg Asn Leu65 70 75 80Leu Leu Asp Gly Ser Gln Ser Leu Thr Cys Met Pro Pro Arg Ile Gly 85 90 95Ser Leu Thr Cys Leu Lys Thr Leu Gly Gln Phe Val Val Gly Arg Lys 100 105 110Lys Gly Tyr Gln Leu Gly Glu Leu Gly Asn Leu Asn Leu Tyr Gly Ser 115 120 125Ile Lys Ile Ser His Leu Glu Arg Val Lys Asn Asp Lys Asp Ala Lys 130 135 140Glu Ala Asn Leu Ser Ala Lys Gly Asn Leu His Ser Leu Ser Met Ser145 150 155 160Trp Asn Asn Phe Gly Pro His Ile Tyr Glu Ser Glu Glu Val Lys Val 165 170 175Leu Glu Ala Leu Lys Pro His Ser Asn Leu Thr Ser Leu Lys Ile Tyr 180 185 190Gly Phe Arg Gly Ile His Leu Pro Glu Trp Met Asn His Ser Val Leu 195 200 205Lys Asn Ile Val Ser Ile Leu Ile Ser Asn Phe Arg Asn Cys Ser Cys 210 215 220Leu Pro Pro Phe Gly Asp Leu Pro Cys Leu Glu Ser Leu Glu Leu His225 230 235 240Trp Gly Ser Ala Asp Val Glu Tyr Val Glu Glu Val Asp Ile Asp Val 245 250 255His Ser Gly Phe Pro Thr Arg Ile Arg Phe Pro Ser Leu Arg Lys Leu 260 265 270Asp Ile Trp Asp Phe Gly Ser Leu Lys Gly Leu Leu Lys Lys Glu Gly 275 280 285Glu Glu Gln Phe Pro Val Leu Glu Glu Met Ile Ile His Glu Cys Pro 290 295 300Phe Leu Thr Leu Ser Ser Asn Leu Arg Ala Leu Thr Ser Leu Arg Ile305 310 315 320Cys Tyr Asn Lys Val Ala Thr Ser Phe Pro Glu Glu Met Phe Lys Asn 325 330 335Leu Ala Asn Leu Lys Tyr Leu Thr Ile Ser Arg Cys Asn Asn Leu Lys 340 345 350Glu Leu Pro Thr Ser Leu Ala Ser Leu Asn Ala Leu Lys Ser Leu Lys 355 360 365Ile Gln Leu Cys Cys Ala Leu Glu Ser Leu Pro Glu Glu Gly Leu Glu 370 375 380Gly Leu Ser Ser Leu Thr Glu Leu Phe Val Glu His Cys Asn Met Leu385 390 395 400Lys Cys Leu Pro Glu Gly Leu Gln His Leu Thr Thr Leu Thr Ser Leu 405 410 415Lys Ile Arg Gly Cys Pro Gln Leu Ile Lys Arg Cys Glu Lys Gly Ile 420 425 430Gly Glu Asp Trp His Lys Ile Ser His Ile Pro Asn Val Asn Ile Tyr 435 440 445Ile 38441PRTSolanum verrucosum 38Leu Gln Lys Phe Val Ser Leu Arg Val Leu Asn Leu Arg Asn Ser Asp1 5 10 15Leu Asn Gln Leu Pro Ser Ser Ile Gly Asp Leu Val His Leu Arg Tyr 20 25 30Leu Asp Leu Ser Asp Asn Ile Arg Ile Arg Ser Leu Pro Lys Arg Leu 35 40 45Cys Lys Leu Gln Asn Leu Gln Thr Leu Asp Leu His Asn Cys Tyr Ser 50 55 60Leu Ser Cys Leu Pro Lys Gln Thr Ser Lys Leu Gly Ser Leu Arg Asn65 70 75 80Leu Leu Leu Asp Gly Cys Ser Leu Thr Ser Thr Pro Pro Arg Ile Gly 85 90 95Leu Leu Thr Cys Leu Lys Ser Leu Ser Cys Phe Val Ile Gly Lys Arg 100 105 110Lys Gly Tyr Gln Leu Gly Glu Leu Lys Asn Leu Asn Leu Tyr Gly Ser 115 120 125Ile Ser Ile Thr Lys Leu Glu Arg Val Lys Lys Gly Arg Asp Ala Lys 130 135 140Glu Ala Asn Ile Phe Val Lys Ala Asn Leu His Ser Leu Ser Leu Ser145 150 155 160Trp Asp Phe Asp Gly Thr His Arg Tyr Glu Ser Glu Val Leu Glu Ala 165 170 175Leu Lys Pro His Ser Asn Leu Lys Tyr Leu Glu Ile Ile Gly Phe Arg 180 185 190Gly Ile Arg Leu Pro Asp Trp Met Asn Gln Ser Val Leu Lys Asn Val 195 200 205Val Ser Ile Thr Ile Arg Gly Cys Glu Asn Cys Ser Cys Leu Pro Pro 210 215 220Phe Gly Glu Leu Pro Ser Leu Glu Ser Leu Glu Leu His Thr Gly Ser225 230 235 240Ala Glu Val Glu Tyr Val Glu Glu Asn Ala His Pro Gly Arg Phe Pro 245 250 255Ser Leu Arg Lys Leu Val Ile Cys Asp Phe Gly Asn Leu Lys Gly Leu 260 265 270Leu Lys Lys Glu Gly Glu Glu Gln Val Pro Val Leu Glu Glu Met Thr 275 280 285Ile His Gly Cys Pro Met Phe Val Ile Pro Thr Leu Ser Ser Val Lys 290 295 300Thr Leu Lys Val Asp Val Thr Asp Ala Thr Val Leu Arg Ser Ile Ser305 310 315 320Asn Leu Arg Ala Leu Thr Ser Leu Asp Ile Ser Ser Asn Tyr Glu Ala 325 330 335Thr Ser Leu Pro Glu Glu Met Phe Lys Asn Leu Ala Asn Leu Lys Asp 340 345 350Leu Thr Ile Ser Asp Phe Lys Asn Leu Lys Glu Leu Pro Thr Cys Leu 355 360 365Ala Ser Leu Asn Ala Leu Asn Ser Leu Gln Ile Glu Tyr Cys Asp Ala 370 375 380Leu Glu Ser Leu Pro Glu Glu Gly Val Lys Ser Leu Thr Ser Leu Thr385 390 395 400Glu Leu Ser Val Ser Asn Cys Met Thr Leu Lys Cys Leu Pro Glu Gly 405 410 415Leu Gln His Leu Thr Ala Leu Thr Thr Leu Ile Ile Thr Gln Cys Pro 420 425 430Ile Val Ile Lys Arg Cys Glu Lys Glu 435 44039441PRTSolanum verrucosum 39Leu Gln Lys Phe Val Ser Leu Arg Val Leu Asn Leu Arg Asn Ser Asp1 5 10 15Leu Asn Gln Leu Pro Ser Ser Ile Gly Asp Val Val His Leu Arg Tyr 20 25 30Leu Asp Leu Ser Asp Asn Ile Arg Ile Arg Ser Leu Pro Lys Arg Leu 35 40 45Cys Lys Leu Gln Asn Leu Gln Thr Leu Asp Leu Arg Asn Cys Tyr Ser 50 55 60Leu Ser Cys Leu Pro Lys Gln Thr Ser Lys Leu Gly Ser Leu Arg Asn65 70 75 80Leu Leu Leu Asp Gly Cys Ser Leu Thr Ser Thr Pro Pro Arg Ile Gly 85 90 95Leu Leu Thr Cys Leu Lys Ser Leu Ser Cys Phe Val Ile Gly Lys Arg 100 105 110Lys Gly Tyr Leu Leu Gly Glu Leu Arg Asn Leu Asn Leu Tyr Gly Ser 115 120 125Ile Ser Ile Thr Lys Leu Glu Arg Val Lys Lys Gly Arg Asp Ala Lys 130 135 140Glu Ala Asn Ile Ser Val Lys Ala Asn Leu His Ser Leu Ser Leu Ser145 150 155 160Trp Asp Phe Asp Gly Thr His Arg Tyr Glu Ser Glu Val Leu Glu Ala 165 170 175Leu Lys Pro His Ser Asn Leu Lys Tyr Leu Glu Ile Ile Gly Phe Arg 180 185 190Gly Ile His Leu Pro Asp Trp Met Asn Gln Ser Val Leu Lys Asn Val 195 200 205Val Ser Ile Thr Ile Arg Gly Cys Glu Asn Cys Ser Cys Leu Pro Pro 210 215 220Phe Gly Glu Leu Pro Ser Leu Glu Ser Leu Glu Leu His Thr Gly Ser225 230 235 240Ala Glu Val Glu Tyr Val Glu Glu Asn Ala His Pro Gly Arg Phe Pro 245 250 255Ser Leu Arg Lys Leu Val Ile Cys Asp Phe Gly Asn Leu Lys Gly Leu 260 265 270Leu Lys Lys Glu Gly Glu Glu Gln Phe Pro Val Leu Glu Glu Met Thr 275 280 285Ile His Gly Cys Pro Met Phe Val Ile Pro Thr Leu Ser Ser Val Lys 290 295 300Thr Leu Lys Val Asp Ala Thr Asp Ala Thr Val Leu Arg Ser Ile Ser305 310 315 320Asn Leu Arg Ala Leu Thr Ser Leu Asp Ile Ser Ser Asn Tyr Glu Ala 325 330 335Thr Ser Leu Pro Glu Glu Met Phe Lys Asn Leu Ala Asn Leu Lys Asp 340 345 350Leu Thr Ile Ser Asp Phe Lys Asn Leu Lys Glu Leu Pro Thr Cys Leu 355 360 365Ala Ser Leu Asn Ala Leu Asn Ser Leu Gln Ile Glu Tyr Cys Asp Ala 370 375 380Leu Glu Ser Leu Pro Glu Glu Gly Val Lys Ser Leu Thr Ser Leu Thr385 390 395 400Glu Leu Ser Val Ser Asn Cys Met Thr Leu Lys Cys Leu Pro Glu Gly 405 410 415Leu Gln His Leu Thr Ala Leu Thr Thr Leu Ile Ile Thr Gln Cys Pro 420 425 430Ile Val Ile Lys Arg Cys Glu Lys Glu 435 44040441PRTSolanum verrucosum 40Leu Gln Lys Phe Val Ser Leu Arg Val Leu Asn Leu Arg Asn Ser Asp1 5 10 15Leu Asn Gln Leu Pro Ser Ser Ile Gly Asp Leu Val His Leu Arg Tyr 20 25 30Leu Asp Leu Ser Asp Asn Ile Arg Ile Arg Ser Leu Pro Lys Arg Leu 35 40 45Cys Glu Leu Gln Asn Leu Gln Thr Leu Asp Leu His Asn Cys Tyr Ser 50 55 60Leu Ser Cys Leu Pro Lys Gln Thr Ser Lys Leu Gly Ser Leu Arg Asn65 70 75 80Leu Leu Leu Asp Gly Cys Ser Leu Thr Ser Thr Pro Pro Arg Ile Gly 85 90 95Leu Leu Thr Cys Leu Lys Ser Leu Ser Cys Phe Val Ile Gly Lys Arg 100 105 110Lys Gly Tyr Gln Leu Gly Glu Leu Lys Asn Leu Asn Leu Tyr Gly Ser 115 120 125Ile Ser Ile Thr Lys Leu Glu Arg Val Lys Lys Gly Arg Asp Ala Lys 130 135 140Glu Ala Asn Ile Ser Val Lys Ala Asn Leu His Ser Leu Ser Leu Ser145 150 155 160Trp Asp Phe Asp Gly Thr His Arg Tyr Glu Ser Glu Val Leu Glu Ala 165 170 175Leu Lys Pro His Ser Asn Leu Lys Tyr Leu Glu Ile Ile Gly Phe Arg 180 185 190Gly Ile Arg Leu Pro Asp Trp Met Asn Gln Ser Val Leu Lys Asn Val 195 200 205Val Ser Ile Thr Ile Arg Gly Cys Glu Asn Cys Ser Cys Leu Pro Pro 210 215 220Phe Gly Glu Leu Pro Ser Leu Glu Ser Leu Glu Leu His Thr Gly Ser225 230 235 240Ala Glu Val Glu Tyr Val Glu Glu Asn Ala His Pro Gly Arg Phe Pro 245 250 255Ser Leu Arg Lys Leu Val Ile Cys Asp Phe Gly Asn Leu Lys Gly Leu 260 265 270Leu Lys Lys Glu Gly Glu Glu Gln Phe Pro Val Leu Glu Glu Met Thr 275 280 285Ile His

Gly Cys Pro Met Phe Val Ile Pro Thr Leu Ser Ser Val Lys 290 295 300Thr Leu Lys Val Asp Val Thr Asp Ala Thr Val Leu Arg Ser Ile Ser305 310 315 320Asn Leu Arg Ala Leu Thr Ser Leu Asp Ile Ser Ser Asn Tyr Glu Ala 325 330 335Thr Ser Leu Pro Glu Glu Met Phe Lys Asn Leu Ala Asn Leu Lys Asp 340 345 350Leu Thr Ile Ser Asp Phe Lys Asn Leu Lys Glu Leu Pro Thr Cys Leu 355 360 365Ala Ser Leu Asn Ala Leu Asn Ser Leu Gln Ile Glu Tyr Cys Asp Ala 370 375 380Leu Glu Ser Leu Pro Glu Glu Gly Val Lys Ser Leu Thr Ser Leu Thr385 390 395 400Glu Leu Ser Val Ser Asn Cys Met Thr Leu Lys Cys Leu Pro Glu Gly 405 410 415Leu Gln His Leu Thr Ala Leu Thr Thr Leu Ile Ile Thr Gln Cys Pro 420 425 430Ile Val Ile Lys Arg Cys Glu Lys Glu 435 44041441PRTSolanum verrucosum 41Leu Gln Lys Phe Val Ser Leu Arg Val Leu Asn Leu Arg Asn Ser Asp1 5 10 15Leu Asn Gln Leu Pro Ser Ser Ile Gly Asp Val Val His Leu Arg Tyr 20 25 30Leu Asp Leu Ser Asp Asn Ile Arg Ile Arg Ser Leu Pro Lys Arg Leu 35 40 45Cys Lys Leu Gln Asn Leu Gln Thr Leu Asp Leu Arg Asn Cys Tyr Ser 50 55 60Leu Ser Cys Leu Pro Lys Gln Thr Ser Lys Leu Gly Ser Leu Arg Asn65 70 75 80Leu Leu Leu Gly Gly Cys Ser Leu Ala Ser Thr Pro Pro Arg Ile Gly 85 90 95Leu Leu Thr Cys Leu Lys Ser Leu Ser Cys Phe Val Ile Gly Lys Arg 100 105 110Lys Gly Tyr Leu Leu Gly Glu Leu Arg Asn Leu Asn Leu Tyr Gly Ser 115 120 125Ile Ser Ile Thr Lys Leu Glu Arg Val Lys Lys Gly Arg Asp Ala Lys 130 135 140Glu Ala Asn Ile Ser Val Lys Ala Asn Leu His Ser Leu Ser Leu Ser145 150 155 160Trp Asp Phe Asp Gly Thr His Arg Tyr Glu Ser Glu Val Leu Glu Ala 165 170 175Leu Lys Pro His Ser Asn Leu Lys Tyr Leu Glu Ile Ile Gly Phe Arg 180 185 190Gly Ile His Leu Pro Asp Trp Met Asn Gln Ser Val Leu Lys Asn Val 195 200 205Val Ser Ile Thr Ile Arg Gly Cys Glu Asn Cys Ser Cys Leu Pro Pro 210 215 220Phe Gly Glu Leu Pro Ser Leu Glu Ser Leu Glu Leu His Thr Gly Ser225 230 235 240Ala Glu Val Glu Tyr Val Glu Glu Asn Ala His Pro Gly Arg Phe Pro 245 250 255Ser Leu Arg Lys Leu Val Ile Cys Asp Phe Gly Asn Leu Lys Gly Leu 260 265 270Leu Lys Lys Glu Gly Glu Glu Gln Phe Pro Val Leu Glu Glu Met Thr 275 280 285Ile His Gly Cys Pro Met Phe Val Ile Pro Thr Leu Ser Ser Val Lys 290 295 300Thr Leu Lys Val Asp Val Thr Asp Ala Thr Val Leu Arg Ser Ile Ser305 310 315 320Asn Leu Arg Ala Leu Thr Ser Leu Asp Ile Ser Ser Asn Tyr Glu Ala 325 330 335Thr Ser Leu Pro Glu Glu Met Phe Lys Asn Leu Ala Asn Leu Lys Asp 340 345 350Leu Thr Ile Ser Asp Phe Lys Asn Leu Lys Glu Leu Pro Thr Cys Leu 355 360 365Ala Ser Leu Asn Ala Leu Asn Ser Leu Gln Ile Glu Tyr Cys Asp Ala 370 375 380Leu Glu Ser Leu Pro Glu Glu Gly Val Lys Ser Leu Thr Ser Leu Thr385 390 395 400Glu Leu Ser Val Ser Asn Cys Met Thr Leu Lys Cys Leu Pro Glu Gly 405 410 415Leu Gln His Leu Thr Ala Leu Thr Thr Leu Ile Ile Ile Gln Cys Pro 420 425 430Ile Val Ile Lys Arg Cys Glu Lys Glu 435 44042441PRTSolanum verrucosum 42Leu Gln Lys Phe Val Ser Leu Arg Val Leu Asn Leu Arg Asn Ser Asp1 5 10 15Leu Asn Gln Leu Pro Ser Ser Ile Gly Asp Leu Val His Leu Arg Tyr 20 25 30Leu Asp Leu Ser Asp Asn Ile Arg Ile Arg Ser Leu Pro Lys Arg Leu 35 40 45Cys Lys Leu Gln Asn Leu Gln Thr Leu Asp Leu His Asn Cys Tyr Ser 50 55 60Leu Ser Cys Leu Pro Lys Gln Thr Ser Lys Leu Gly Ser Leu Arg Asn65 70 75 80Leu Leu Leu Asp Gly Cys Ser Leu Thr Ser Thr Pro Pro Arg Ile Gly 85 90 95Leu Leu Thr Cys Leu Lys Ser Leu Ser Cys Phe Val Ile Gly Lys Arg 100 105 110Lys Gly Tyr Gln Leu Gly Glu Leu Lys Asn Leu Asn Leu Tyr Gly Ser 115 120 125Ile Ser Ile Thr Lys Leu Glu Arg Val Lys Lys Gly Arg Asp Ala Lys 130 135 140Glu Ala Asn Ile Ser Val Lys Ala Asn Leu His Ser Leu Ser Leu Ser145 150 155 160Trp Asp Phe Asp Gly Thr His Arg Tyr Glu Ser Glu Val Leu Glu Ala 165 170 175Leu Lys Pro His Ser Asn Leu Lys Tyr Leu Glu Ile Ile Gly Phe Arg 180 185 190Gly Ile Arg Leu Pro Asp Trp Met Asn Gln Ser Val Leu Lys Asn Val 195 200 205Val Ser Ile Thr Ile Arg Gly Cys Glu Asn Cys Ser Cys Leu Pro Pro 210 215 220Phe Gly Glu Leu Pro Ser Leu Glu Ser Leu Glu Leu His Thr Gly Ser225 230 235 240Ala Glu Val Glu Tyr Val Glu Glu Asn Ala His Pro Gly Arg Phe Pro 245 250 255Ser Leu Arg Lys Leu Val Ile Cys Asp Phe Gly Asn Leu Lys Gly Leu 260 265 270Leu Lys Lys Glu Gly Glu Glu Gln Phe Pro Val Leu Glu Glu Met Thr 275 280 285Ile His Gly Cys Pro Met Phe Val Ile Pro Thr Leu Ser Ser Val Lys 290 295 300Thr Leu Lys Val Asp Val Thr Asp Ala Thr Val Leu Arg Ser Ile Ser305 310 315 320Asn Leu Arg Ala Leu Thr Ser Leu Asp Ile Ser Ser Asn Tyr Glu Ala 325 330 335Thr Ser Leu Pro Glu Glu Met Phe Lys Asn Leu Ala Asp Leu Lys Asp 340 345 350Leu Thr Ile Ser Asp Phe Lys Asn Leu Lys Glu Leu Pro Thr Cys Leu 355 360 365Ala Ser Leu Asn Ala Leu Asn Ser Leu Gln Ile Glu Tyr Cys Asp Ala 370 375 380Leu Glu Ser Leu Pro Glu Glu Gly Val Lys Ser Leu Thr Ser Leu Thr385 390 395 400Glu Leu Ser Val Ser Asn Cys Met Thr Leu Lys Cys Leu Pro Glu Gly 405 410 415Leu Gln His Leu Thr Ala Leu Thr Thr Leu Ile Ile Thr Gln Cys Pro 420 425 430Ile Val Ile Lys Arg Cys Glu Lys Glu 435 44043441PRTSolanum verrucosum 43Leu Gln Lys Phe Val Ser Leu Arg Val Leu Asn Leu Arg Asn Ser Asp1 5 10 15Leu Asn Gln Leu Pro Ser Ser Ile Gly Asp Val Val His Leu Arg Tyr 20 25 30Leu Asp Leu Ser Asp Asn Ile Arg Ile Arg Ser Leu Pro Lys Arg Leu 35 40 45Cys Lys Leu Gln Asn Leu Gln Thr Leu Asp Leu Arg Asn Cys Tyr Ser 50 55 60Leu Ser Cys Leu Pro Lys Gln Thr Ser Lys Leu Gly Ser Leu Arg Asn65 70 75 80Leu Leu Leu Gly Gly Cys Ser Leu Thr Ser Thr Pro Pro Arg Ile Gly 85 90 95Leu Leu Thr Cys Leu Lys Ser Leu Ser Arg Phe Val Ile Gly Lys Arg 100 105 110Lys Gly Tyr Leu Leu Gly Glu Leu Arg Asn Leu Asn Leu Tyr Gly Ser 115 120 125Ile Ser Ile Thr Lys Leu Glu Arg Val Lys Lys Gly Arg Asp Ala Lys 130 135 140Glu Ala Asn Ile Ser Val Lys Ala Asn Leu His Ser Leu Ser Leu Ser145 150 155 160Trp Asp Phe Asp Gly Thr His Arg Tyr Glu Ser Glu Val Leu Glu Ala 165 170 175Leu Lys Pro His Ser Asn Leu Lys Tyr Leu Glu Ile Ile Gly Phe Arg 180 185 190Gly Ile His Leu Pro Asp Trp Met Asn Gln Ser Val Leu Lys Asn Val 195 200 205Val Ser Ile Thr Ile Arg Gly Cys Glu Asn Cys Ser Cys Leu Pro Pro 210 215 220Phe Gly Glu Leu Pro Ser Leu Glu Ser Leu Glu Leu His Thr Gly Ser225 230 235 240Ala Glu Val Glu Tyr Val Glu Glu Asn Ala His Pro Gly Arg Phe Pro 245 250 255Ser Leu Arg Lys Leu Val Ile Cys Asp Phe Gly Asn Leu Lys Gly Leu 260 265 270Leu Lys Lys Glu Gly Glu Glu Gln Phe Pro Val Leu Glu Glu Met Thr 275 280 285Ile His Gly Cys Pro Met Phe Val Ile Pro Thr Leu Ser Ser Val Lys 290 295 300Thr Leu Lys Val Asp Val Thr Asp Ala Thr Val Leu Arg Ser Ile Ser305 310 315 320Asn Leu Arg Ala Leu Thr Ser Leu Asp Ile Ser Ser Asn Tyr Glu Ala 325 330 335Thr Ser Leu Pro Glu Glu Met Phe Lys Asn Leu Ala Asn Leu Lys Asp 340 345 350Leu Thr Ile Ser Asp Phe Lys Asn Leu Lys Glu Leu Pro Thr Cys Leu 355 360 365Ala Ser Leu Asn Ala Leu Asn Ser Leu Gln Ile Glu Tyr Cys Asp Ala 370 375 380Leu Glu Ser Leu Pro Glu Glu Gly Val Lys Ser Leu Thr Ser Leu Thr385 390 395 400Glu Leu Ser Val Ser Asn Cys Met Thr Leu Lys Cys Leu Pro Glu Gly 405 410 415Leu Gln His Leu Thr Ala Leu Thr Thr Leu Ile Ile Ile Gln Cys Pro 420 425 430Ile Val Ile Lys Arg Cys Glu Lys Glu 435 44044441PRTSolanum verrucosum 44Leu Gln Lys Phe Val Ser Leu Arg Val Leu Asn Leu Arg Asn Ser Asp1 5 10 15Leu Asn Gln Leu Pro Ser Ser Ile Gly Asp Val Val His Leu Arg Tyr 20 25 30Leu Asp Leu Ser Asp Asn Ile Arg Ile Arg Ser Leu Pro Lys Arg Leu 35 40 45Cys Lys Leu Gln Asn Leu Gln Thr Leu Asp Leu Arg Asn Cys Tyr Ser 50 55 60Leu Ser Cys Leu Pro Lys Gln Thr Ser Lys Leu Gly Ser Leu Arg Asn65 70 75 80Leu Leu Leu Gly Gly Cys Ser Leu Thr Ser Thr Pro Pro Arg Ile Gly 85 90 95Leu Leu Thr Cys Leu Lys Ser Leu Ser Cys Phe Val Ile Gly Lys Arg 100 105 110Lys Gly Tyr Leu Leu Gly Glu Leu Arg Asn Leu Asn Leu Tyr Gly Ser 115 120 125Ile Ser Ile Thr Lys Leu Glu Arg Val Lys Lys Gly Arg Asp Ala Lys 130 135 140Glu Ala Asn Ile Ser Val Lys Ala Asn Leu His Ser Leu Ser Leu Ser145 150 155 160Trp Asp Phe Asp Gly Thr His Arg Tyr Glu Ser Glu Val Leu Glu Ala 165 170 175Leu Lys Pro His Ser Asn Leu Lys Tyr Leu Glu Ile Ile Gly Phe Arg 180 185 190Gly Ile His Leu Pro Asp Trp Met Asn Gln Ser Val Leu Lys Asn Val 195 200 205Val Ser Ile Thr Ile Arg Gly Cys Glu Asn Cys Ser Cys Leu Pro Pro 210 215 220Phe Gly Glu Leu Pro Ser Leu Glu Ser Leu Glu Leu His Thr Gly Ser225 230 235 240Ala Glu Val Glu Tyr Val Glu Glu Asn Ala His Pro Gly Arg Phe Pro 245 250 255Ser Leu Arg Lys Leu Val Ile Cys Asp Phe Gly Asn Leu Lys Gly Leu 260 265 270Leu Lys Lys Glu Gly Glu Glu Gln Phe Pro Val Leu Glu Glu Met Thr 275 280 285Ile His Gly Cys Pro Met Phe Val Ile Pro Thr Leu Ser Ser Val Lys 290 295 300Thr Leu Lys Val Asp Val Thr Asp Ala Thr Val Leu Arg Ser Ile Ser305 310 315 320Asn Leu Arg Ala Leu Thr Ser Leu Asp Ile Ser Ser Asn Tyr Glu Ala 325 330 335Thr Ser Leu Pro Glu Glu Met Phe Lys Asn Leu Ala Asn Leu Lys Asp 340 345 350Leu Thr Ile Ser Asp Phe Lys Asn Leu Lys Glu Leu Pro Thr Cys Leu 355 360 365Ala Ser Leu Asn Ala Leu Asn Ser Leu Gln Ile Glu Tyr Cys Asp Ala 370 375 380Leu Glu Ser Leu Pro Glu Glu Gly Val Lys Ser Leu Thr Ser Leu Thr385 390 395 400Glu Leu Ser Val Ser Asn Cys Met Thr Leu Lys Cys Leu Pro Glu Gly 405 410 415Leu Gln His Leu Thr Ala Leu Thr Thr Leu Ile Ile Ile Gln Cys Pro 420 425 430Ile Val Ile Lys Arg Cys Glu Lys Glu 435 44045441PRTSolanum verrucosum 45Leu Gln Lys Phe Val Ser Leu Arg Val Leu Asn Leu Arg Asn Ser Asp1 5 10 15Leu Asn Gln Leu Pro Ser Ser Ile Gly Asp Val Val His Leu Arg Tyr 20 25 30Leu Asp Leu Ser Asp Asn Ile Arg Ile Arg Ser Leu Pro Lys Arg Leu 35 40 45Cys Lys Leu Gln Asn Leu Gln Thr Leu Asp Leu Arg Asn Cys Tyr Ser 50 55 60Leu Ser Cys Leu Pro Lys Gln Thr Ser Lys Leu Gly Ser Leu Arg Asn65 70 75 80Leu Leu Leu Asp Gly Cys Ser Leu Thr Ser Thr Pro Pro Arg Ile Gly 85 90 95Leu Leu Thr Cys Leu Lys Ser Leu Ser Cys Phe Val Ile Gly Lys Arg 100 105 110Lys Gly Tyr Leu Leu Gly Glu Leu Arg Asn Leu Asn Leu Tyr Gly Ser 115 120 125Ile Ser Ile Thr Lys Leu Glu Arg Val Lys Lys Gly Arg Asp Ala Lys 130 135 140Glu Ala Asn Ile Ser Val Lys Ala Asn Leu His Ser Leu Ser Leu Ser145 150 155 160Trp Asp Phe Asp Gly Thr His Arg Tyr Glu Ser Glu Val Leu Glu Ala 165 170 175Leu Lys Pro His Ser Asn Leu Lys Tyr Leu Glu Ile Ile Gly Phe Arg 180 185 190Gly Ile His Leu Pro Asp Trp Met Asn Gln Ser Val Leu Lys Asn Val 195 200 205Val Ser Ile Thr Ile Arg Gly Cys Glu Asn Tyr Ser Cys Leu Pro Pro 210 215 220Phe Gly Glu Leu Pro Ser Leu Glu Ser Leu Glu Leu His Thr Gly Ser225 230 235 240Ala Glu Val Glu Tyr Val Glu Glu Asn Ala His Pro Gly Arg Phe Pro 245 250 255Ser Leu Arg Lys Leu Val Ile Cys Asp Phe Gly Asn Leu Lys Gly Leu 260 265 270Leu Lys Lys Glu Gly Glu Glu Gln Phe Pro Val Leu Glu Glu Met Ser 275 280 285Ile His Gly Cys Pro Met Phe Val Ile Pro Thr Leu Ser Ser Val Lys 290 295 300Thr Leu Lys Val Asp Val Ala Asp Ala Thr Val Leu Arg Ser Ile Ser305 310 315 320Asn Leu Arg Ala Leu Thr Ser Leu Asp Ile Ser Ser Asn Tyr Glu Ala 325 330 335Thr Ser Leu Pro Glu Glu Met Phe Lys Asn Leu Ala Asn Leu Lys Asp 340 345 350Leu Thr Ile Ser Asp Phe Lys Asn Leu Lys Glu Leu Pro Thr Cys Leu 355 360 365Ala Ser Leu Asn Ala Leu Asn Ser Leu Gln Ile Glu Tyr Cys Asp Ala 370 375 380Leu Glu Ser Leu Pro Glu Glu Gly Val Lys Ser Leu Thr Ser Leu Thr385 390 395 400Glu Leu Ser Val Ser Asn Cys Met Thr Leu Lys Cys Leu Pro Glu Gly 405 410 415Leu Gln His Leu Thr Ala Leu Thr Thr Leu Ile Ile Ile Gln Cys Pro 420 425 430Ile Val Ile Lys Arg Cys Glu Lys Glu 435 440